KP1331 personal page - To The Moon

KP1331

No personal profile

297Follow

3Followers

0Topic

0Badge

2021-06-26

Nice

US IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week

2021-04-04

Great

U.S. added 916,000 jobs in March, above expectations

2021-03-16

Cool

Stripe now most valuable US startup

2021-03-08

Buy the dip!!

A Stock Market Crash May Be Coming: 6 Metrics You'll Want to Know

2021-03-05

Nice

GM evaluating second U.S. battery plant for EVs amid construction of $2.3 billion facility in Ohio

2021-03-04

Nice

Sorry, the original content has been removed

2021-03-03

Cool

Ting Hsin Weighing $800 Million IPO of KFC’s Chinese Rival

2021-03-02

Good

Is AMD Stock A Buy After Chipmaker's Fourth-Quarter Earnings Report?

2021-03-01

Nice

Oil prices drop amid U.S. dollar strength, expectations for supply gains

2021-02-27

Nice

Pfizer COVID-19 vaccine reduces transmission after one dose -UK study

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3574123214878817","uuid":"3574123214878817","gmtCreate":1611029191378,"gmtModify":1611029191378,"name":"KP1331","pinyin":"kp1331","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":3,"headSize":297,"tweetSize":11,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.10.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":125178979,"gmtCreate":1624666188291,"gmtModify":1703843017056,"author":{"id":"3574123214878817","authorId":"3574123214878817","name":"KP1331","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574123214878817","authorIdStr":"3574123214878817"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/125178979","repostId":"1134306371","repostType":4,"repost":{"id":"1134306371","kind":"news","pubTimestamp":1624665868,"share":"https://ttm.financial/m/news/1134306371?lang=&edition=fundamental","pubTime":"2021-06-26 08:04","market":"us","language":"en","title":"US IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1134306371","media":"Renaissance Capital","summary":"16 IPOs went public in another active week for the IPO market, led by digital physicians network Dox","content":"<p>16 IPOs went public in another active week for the IPO market, led by digital physicians network&nbsp;<b>Doximity</b>(DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as one postponement, Chinese social networking platform&nbsp;<b>Soulgate</b>(SSR).</p>\n<p><b>Doximity</b>&nbsp;(DOCS) priced above the range to raise $606 million at a $5.5 billion market cap. Doximity claims that it is the leading digital platform for US medical professionals, allowing collaboration with colleagues and secure coordination of patient care, among other features. While growth may slow as conditions normalize post-pandemic, the company has a sticky customer base and strong track record of profitability. Doximity finished up 115%.</p>\n<p>The largest deal of the week, Chinese freight platform&nbsp;<b>Full Truck Alliance</b>(YMM) priced at the high end to raise $1.6 billion at a $20.8 billion market cap. Full Truck states that it is the world's largest digital freight platform by gross transaction value (GTV), facilitating 22+ million fulfilled orders with GTV of nearly $8 billion in the 1Q21. The company is unprofitable though free cash flow turned positive in 2020. Full Truck finished up 4%.</p>\n<p>Integrated insurer&nbsp;<b>Bright Health Group</b>(BHG) downsized and priced below the range to raise $924 million at a $12.7 billion market cap. Through a multi-pronged organic and inorganic growth strategy, the company’s core business has grown to serve roughly 623,000 patients in 14 states since its founding. However, the company is unprofitable, and its medical cost ratio has increased over the last several years. Bright Health finished down 4%.</p>\n<p><b>Confluent</b>(CFLT) priced above the range to raise $828 million at an $11.7 billion market cap. Founded by the original creators of Apache Kafka, Confluent’s data infrastructure offering is designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. The company has demonstrated growth but S&amp;M spending has widened losses. Confluent finished up 28%.</p>\n<p>Car wash brand&nbsp;<b>Mister Car Wash</b>(MCW) priced at the low end to raise $563 million at a $4.9 billion market cap. Profitable with strong margins and solid cash flow, Mister Car Wash is the largest national car wash brand in the US, with 344 locations in 21 states. The company is slightly concentrated in certain states, and it is leveraged post-IPO. Mister Car Wash finished up 35%.</p>\n<p>HR services provider&nbsp;<b>First Advantage</b>(FA) upsized and priced at the high end to raise $383 million at a $2.3 billion market cap. Profitable with positive cash flow, First Advantage provides solutions for screening, verifications, safety, and compliance related to human capital. The company operates in a highly competitive market, and revenue depends on hiring rates. First Advantage finished up 37%.</p>\n<p>Chinese grocery delivery platform&nbsp;<b>Missfresh</b>(MF) priced at the low end to raise $273 million at a $3.2 billion market cap. Missfresh’s mobile app and Mini Program allow consumers to purchase groceries from their phone, which are then delivered to their door by a delivery driver. The company is a leader in its market, though it is unprofitable, and revenue declined in the 1Q21. Missfresh finished down 26%.</p>\n<p>Customer experience software provider&nbsp;<b>Sprinklr</b>(CXM) downsized and priced below the range to raise $266 million at a $4.6 billion market cap. Sprinklr provides a software platform that helps enterprises create a persistent, unified view of each customer at scale. The company has improved its gross margins, though it is historically unprofitable due to high S&amp;M costs. Sprinklr finished up 28%.</p>\n<p>Gene editing biotech&nbsp;<b>Graphite Bio</b>(GRPH) upsized and priced at the high end to raise $238 million at a $999 million market cap. Graphite's lead candidate aims to correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expression. The company has received IND clearance and intends to enroll a Phase 1/2 trial in the 2H21, with initial data expected by the end of 2022. Graphite finished up 9%.</p>\n<p>Oncology biotech&nbsp;<b>Monte Rosa Therapeutics</b>(GLUE) upsized and priced at the high end to raise $222 million at a $911 million market cap. The company plans to select one of its selective, orally bioavailable GSPT1-directed MGD molecules for use in a genetically-defined subset of non-small cell lung cancer patients by the 2H21, and submit an IND in the 1H22. Monte Rosa finished down 1%.</p>\n<p>Irish DMT biotech&nbsp;<b>GH Research</b>(GHRS) upsized and priced at the high end to raise $160 million at an $809 million market cap. The company is developing its proprietary 5-MeO-DMT compound in a Phase 2 trial in the Netherlands for patients with Treatment-Resistant Depression. GH Research finished up 20%.</p>\n<p>Oncology biotech&nbsp;<b>Elevation Oncology</b>(ELEV) priced at the midpoint to raise $100 million at a $403 million market cap. Elevation's lead program is focused on neuregulin-1, or NRG1, fusions. It has initiated a Phase 2 trial of seribantumab, an anti-HER3 monoclonal antibody, in advanced solid tumors harboring an NRG1 fusion. Elevation finished down 29%.</p>\n<p>Biopharmaceutical reagents provider&nbsp;<b>Alpha Teknova</b>(TKNO) upsized and priced at the high end to raise $96 million at a $470 million market cap. Alpha Teknova provides critical reagents that enable the discovery, research, development and production of biopharmaceutical products. As of March 31, 2021, Alpha Teknova had over 3,000 active customers. Alpha Teknova finished up 56%.</p>\n<p><b>Miromatrix Medical</b>&nbsp;(MIRO) upsized and priced at the high end to raise $43 million at a $191 million market cap. Miromatrix is developing a novel technology for bioengineering fully transplantable organs, initially focused on livers and kidneys. The company has demonstrated functional vasculature and important organ function in preclinical studies, and hopes to initiate a Phase 1 trial in late 2022 with its External Liver Assist Product. Miromatrix finished up 42%.</p>\n<p>Antibiotic biotech&nbsp;<b>Acurx Pharmaceuticals</b>(ACXP) priced at the midpoint to raise $15 million at a $62 million market cap. The company is developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the WHO, CDC, and USDA. Its lead candidate recently completed a Phase 2a trial in patients with C. difficile infections, and is expected to begin a Phase 2b trial this year. Acurx finished up 32%.</p>\n<p>CBD products maker&nbsp;<b>Grove</b>(GRVI) priced at the midpoint to raise $11 million at a $79 million market cap. Fast growing and profitable in the 9mo FY21, Grove develops, produces, markets, and sells raw materials, white label products, and end consumer products containing the industrial hemp plant extract, Cannabidiol (CBD). Grove finished up 57%.</p>\n<p>Four SPACs raised $520 million led by&nbsp;<b>FinTech Acquisition VI</b>(FTVIU), which raised $220 million.</p>\n<p><img src=\"https://static.tigerbbs.com/ddaee6ee8ea0594af65c20afe2b09fb2\" tg-width=\"1057\" tg-height=\"708\"><img src=\"https://static.tigerbbs.com/adbfd8143d6b3c07799a5b5568126eae\" tg-width=\"1059\" tg-height=\"498\"></p>\n<p>23 IPOs submitted initial filings. Chinese vaping brand&nbsp;<b>Aspire Global</b>(ASPG) plans to raise $161 million. Fitness franchise&nbsp;<b>F45 Training</b>(FXLV), luxury social club operator&nbsp;<b>Membership Collective</b>(MCG), soft drink maker&nbsp;<b>Zevia</b>(ZVIA), specialty insurer&nbsp;<b>Ryan Specialty Group</b>(RYAN), ocular medical device maker&nbsp;<b>Sight Sciences</b>(SGHT), Italy-based<b>Stevanato Group</b>(STVN), real estate manager&nbsp;<b>Bridge Investment Group</b>(BRDG), consumer banking platform&nbsp;<b>Blend Labs</b>(BLND), database developer<b>Couchbase</b>(BASE), interior design software provider&nbsp;<b>Manycore Tech</b>(KOOL), Chinese tutoring platform&nbsp;<b>Spark Education</b>(SPRK), oncology biotech&nbsp;<b>Vividion Therapeutics</b>(VVID), e-commerce platform&nbsp;<b>VTEX</b>(VTEX), digital marketing services provider&nbsp;<b>Gambling.com Group</b>(GAMB), bone marrow disease biotech&nbsp;<b>Imago BioSciences</b>(IMGO), French biotech&nbsp;<b>Dynacure</b>(DYCU), microbial testing device provider&nbsp;<b>Rapid Micro Biosystems</b>(RPID), legal software provider&nbsp;<b>CS Disco</b>(LAW), oncology biotechs&nbsp;<b>Erasca</b>(ERAS) and&nbsp;<b>Candel Therapeutics</b>(CADL), and fitness franchisor&nbsp;<b>Xponential Fitness</b>(XPOF) all filed to raise $100 million. Medical imaging software provider&nbsp;<b>Perspectum Group</b>(SCAN) filed to raise $75 million.</p>\n<p>10 SPACs submitted initial filings led by Sagansky and Sloan’s&nbsp;<b>Spinning Eagle Acquisition</b>(SPNGU), which plans to raise $2 billion.</p>\n<img src=\"https://static.tigerbbs.com/5405c3b71416d44598b8debbc72ba0c6\" tg-width=\"1059\" tg-height=\"707\">\n<img src=\"https://static.tigerbbs.com/7d74d7af7f2c5dced4672868bf036d03\" tg-width=\"1058\" tg-height=\"663\">\n<img src=\"https://static.tigerbbs.com/1e4854a0e989f2eb5923924d3cdf1083\" tg-width=\"1060\" tg-height=\"554\">\n<p>This past week, Renaissance Capital released its2Q 2021 US IPO Market Review, exploring the second quarter’s record-breaking activity, best and worst performers, and outlook for the 3Q.</p>\n<p><b>IPO Market Snapshot</b></p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 6/24/21, the Renaissance IPO Index was up 2.7% year-to-date, while the S&amp;P 500 was up 13.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 1.5% year-to-date, while the ACWX was up 10.3%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.</p>\n<table>\n <thead>\n  <tr></tr>\n </thead>\n</table>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-26 08:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/83314/US-IPO-Weekly-Recap-Doximity-pops-more-than-100-in-a-16-IPO-week><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>16 IPOs went public in another active week for the IPO market, led by digital physicians network Doximity(DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/83314/US-IPO-Weekly-Recap-Doximity-pops-more-than-100-in-a-16-IPO-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","CFLT":"Confluent, Inc.","FA":"First Advantage Corp.","MF":"每日优鲜","GHRS":"GH Research PLC","DOCS":"Doximity, Inc.","ELEV":"Elevation Oncology, Inc.","CXM":"Sprinklr, Inc.","GLUE":"Monte Rosa Therapeutics",".DJI":"道琼斯","TKNO":"Alpha Teknova, Inc.","ACXP":"Acurx Pharmaceuticals, LLC*","MCW":"Mister Car Wash, Inc.","YMM":"满帮",".IXIC":"NASDAQ Composite"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/83314/US-IPO-Weekly-Recap-Doximity-pops-more-than-100-in-a-16-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134306371","content_text":"16 IPOs went public in another active week for the IPO market, led by digital physicians network Doximity(DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as one postponement, Chinese social networking platform Soulgate(SSR).\nDoximity (DOCS) priced above the range to raise $606 million at a $5.5 billion market cap. Doximity claims that it is the leading digital platform for US medical professionals, allowing collaboration with colleagues and secure coordination of patient care, among other features. While growth may slow as conditions normalize post-pandemic, the company has a sticky customer base and strong track record of profitability. Doximity finished up 115%.\nThe largest deal of the week, Chinese freight platform Full Truck Alliance(YMM) priced at the high end to raise $1.6 billion at a $20.8 billion market cap. Full Truck states that it is the world's largest digital freight platform by gross transaction value (GTV), facilitating 22+ million fulfilled orders with GTV of nearly $8 billion in the 1Q21. The company is unprofitable though free cash flow turned positive in 2020. Full Truck finished up 4%.\nIntegrated insurer Bright Health Group(BHG) downsized and priced below the range to raise $924 million at a $12.7 billion market cap. Through a multi-pronged organic and inorganic growth strategy, the company’s core business has grown to serve roughly 623,000 patients in 14 states since its founding. However, the company is unprofitable, and its medical cost ratio has increased over the last several years. Bright Health finished down 4%.\nConfluent(CFLT) priced above the range to raise $828 million at an $11.7 billion market cap. Founded by the original creators of Apache Kafka, Confluent’s data infrastructure offering is designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. The company has demonstrated growth but S&M spending has widened losses. Confluent finished up 28%.\nCar wash brand Mister Car Wash(MCW) priced at the low end to raise $563 million at a $4.9 billion market cap. Profitable with strong margins and solid cash flow, Mister Car Wash is the largest national car wash brand in the US, with 344 locations in 21 states. The company is slightly concentrated in certain states, and it is leveraged post-IPO. Mister Car Wash finished up 35%.\nHR services provider First Advantage(FA) upsized and priced at the high end to raise $383 million at a $2.3 billion market cap. Profitable with positive cash flow, First Advantage provides solutions for screening, verifications, safety, and compliance related to human capital. The company operates in a highly competitive market, and revenue depends on hiring rates. First Advantage finished up 37%.\nChinese grocery delivery platform Missfresh(MF) priced at the low end to raise $273 million at a $3.2 billion market cap. Missfresh’s mobile app and Mini Program allow consumers to purchase groceries from their phone, which are then delivered to their door by a delivery driver. The company is a leader in its market, though it is unprofitable, and revenue declined in the 1Q21. Missfresh finished down 26%.\nCustomer experience software provider Sprinklr(CXM) downsized and priced below the range to raise $266 million at a $4.6 billion market cap. Sprinklr provides a software platform that helps enterprises create a persistent, unified view of each customer at scale. The company has improved its gross margins, though it is historically unprofitable due to high S&M costs. Sprinklr finished up 28%.\nGene editing biotech Graphite Bio(GRPH) upsized and priced at the high end to raise $238 million at a $999 million market cap. Graphite's lead candidate aims to correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expression. The company has received IND clearance and intends to enroll a Phase 1/2 trial in the 2H21, with initial data expected by the end of 2022. Graphite finished up 9%.\nOncology biotech Monte Rosa Therapeutics(GLUE) upsized and priced at the high end to raise $222 million at a $911 million market cap. The company plans to select one of its selective, orally bioavailable GSPT1-directed MGD molecules for use in a genetically-defined subset of non-small cell lung cancer patients by the 2H21, and submit an IND in the 1H22. Monte Rosa finished down 1%.\nIrish DMT biotech GH Research(GHRS) upsized and priced at the high end to raise $160 million at an $809 million market cap. The company is developing its proprietary 5-MeO-DMT compound in a Phase 2 trial in the Netherlands for patients with Treatment-Resistant Depression. GH Research finished up 20%.\nOncology biotech Elevation Oncology(ELEV) priced at the midpoint to raise $100 million at a $403 million market cap. Elevation's lead program is focused on neuregulin-1, or NRG1, fusions. It has initiated a Phase 2 trial of seribantumab, an anti-HER3 monoclonal antibody, in advanced solid tumors harboring an NRG1 fusion. Elevation finished down 29%.\nBiopharmaceutical reagents provider Alpha Teknova(TKNO) upsized and priced at the high end to raise $96 million at a $470 million market cap. Alpha Teknova provides critical reagents that enable the discovery, research, development and production of biopharmaceutical products. As of March 31, 2021, Alpha Teknova had over 3,000 active customers. Alpha Teknova finished up 56%.\nMiromatrix Medical (MIRO) upsized and priced at the high end to raise $43 million at a $191 million market cap. Miromatrix is developing a novel technology for bioengineering fully transplantable organs, initially focused on livers and kidneys. The company has demonstrated functional vasculature and important organ function in preclinical studies, and hopes to initiate a Phase 1 trial in late 2022 with its External Liver Assist Product. Miromatrix finished up 42%.\nAntibiotic biotech Acurx Pharmaceuticals(ACXP) priced at the midpoint to raise $15 million at a $62 million market cap. The company is developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the WHO, CDC, and USDA. Its lead candidate recently completed a Phase 2a trial in patients with C. difficile infections, and is expected to begin a Phase 2b trial this year. Acurx finished up 32%.\nCBD products maker Grove(GRVI) priced at the midpoint to raise $11 million at a $79 million market cap. Fast growing and profitable in the 9mo FY21, Grove develops, produces, markets, and sells raw materials, white label products, and end consumer products containing the industrial hemp plant extract, Cannabidiol (CBD). Grove finished up 57%.\nFour SPACs raised $520 million led by FinTech Acquisition VI(FTVIU), which raised $220 million.\n\n23 IPOs submitted initial filings. Chinese vaping brand Aspire Global(ASPG) plans to raise $161 million. Fitness franchise F45 Training(FXLV), luxury social club operator Membership Collective(MCG), soft drink maker Zevia(ZVIA), specialty insurer Ryan Specialty Group(RYAN), ocular medical device maker Sight Sciences(SGHT), Italy-basedStevanato Group(STVN), real estate manager Bridge Investment Group(BRDG), consumer banking platform Blend Labs(BLND), database developerCouchbase(BASE), interior design software provider Manycore Tech(KOOL), Chinese tutoring platform Spark Education(SPRK), oncology biotech Vividion Therapeutics(VVID), e-commerce platform VTEX(VTEX), digital marketing services provider Gambling.com Group(GAMB), bone marrow disease biotech Imago BioSciences(IMGO), French biotech Dynacure(DYCU), microbial testing device provider Rapid Micro Biosystems(RPID), legal software provider CS Disco(LAW), oncology biotechs Erasca(ERAS) and Candel Therapeutics(CADL), and fitness franchisor Xponential Fitness(XPOF) all filed to raise $100 million. Medical imaging software provider Perspectum Group(SCAN) filed to raise $75 million.\n10 SPACs submitted initial filings led by Sagansky and Sloan’s Spinning Eagle Acquisition(SPNGU), which plans to raise $2 billion.\n\n\n\nThis past week, Renaissance Capital released its2Q 2021 US IPO Market Review, exploring the second quarter’s record-breaking activity, best and worst performers, and outlook for the 3Q.\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 6/24/21, the Renaissance IPO Index was up 2.7% year-to-date, while the S&P 500 was up 13.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 1.5% year-to-date, while the ACWX was up 10.3%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.","news_type":1},"isVote":1,"tweetType":1,"viewCount":254,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":340781774,"gmtCreate":1617493305498,"gmtModify":1704699937445,"author":{"id":"3574123214878817","authorId":"3574123214878817","name":"KP1331","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574123214878817","authorIdStr":"3574123214878817"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/340781774","repostId":"1176602902","repostType":4,"repost":{"id":"1176602902","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1617366683,"share":"https://ttm.financial/m/news/1176602902?lang=&edition=fundamental","pubTime":"2021-04-02 20:31","market":"us","language":"en","title":"U.S. added 916,000 jobs in March, above expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=1176602902","media":"Tiger Newspress","summary":"(April 2) Job growth boomed in March at the fastest pace since last summer as stronger economic grow","content":"<p>(April&nbsp;2)&nbsp;Job growth boomed in March at the fastest pace since last summer as stronger economic growth and an aggressive vaccination effort pushed companies to step up hiring, the Labor Department reported Friday.</p><p>Nonfarm payrolls increased by 916,000 for the month while the unemployment rate fell to 6%.</p><p>Economists surveyed by Dow Jones had been looking for an increase of 675,000 and an unemployment rate of 6%.</p><p>The report comes amid a slew of other indicators pointing to stronger growth as the U.S. tries to shake off the effects of the Covid-19 pandemic. States and municipalities across the country continue to reopen after a year of operating at reduced capacity.</p><p>Business activity has returned to close to normal levels in much of the company despite the restrictions, with a tracker by Jeffries indicating that activity is at 93.5% of its pre-pandemic level.</p><p>Data from Homebase shows that employees working and hours worked both gained sharply over the past month, with significant improvements in both hospitality and entertainment. Those have been the hardest-hit sectors, but have improved over the past two months as governments have loosened up on some of the harshest restrictions on activity.</p><p>At the same time, manufacturing is enjoying a boom, with an Institute for Supply Management gauge of activity in the sector hitting its highest level since late 1983 in March.</p><p>The pace of gains combined with the unprecedented level of government stimulus has kindled worries about inflation, though Federal Reserve officials say any increases will be temporary.</p><p>The Fed is keeping a close eye on the jobs data, but policymakers have said repeatedly that even with the recent improvements the labor market is nowhere near a point that would push the central bank into raising interest rates.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. added 916,000 jobs in March, above expectations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. added 916,000 jobs in March, above expectations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-04-02 20:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(April&nbsp;2)&nbsp;Job growth boomed in March at the fastest pace since last summer as stronger economic growth and an aggressive vaccination effort pushed companies to step up hiring, the Labor Department reported Friday.</p><p>Nonfarm payrolls increased by 916,000 for the month while the unemployment rate fell to 6%.</p><p>Economists surveyed by Dow Jones had been looking for an increase of 675,000 and an unemployment rate of 6%.</p><p>The report comes amid a slew of other indicators pointing to stronger growth as the U.S. tries to shake off the effects of the Covid-19 pandemic. States and municipalities across the country continue to reopen after a year of operating at reduced capacity.</p><p>Business activity has returned to close to normal levels in much of the company despite the restrictions, with a tracker by Jeffries indicating that activity is at 93.5% of its pre-pandemic level.</p><p>Data from Homebase shows that employees working and hours worked both gained sharply over the past month, with significant improvements in both hospitality and entertainment. Those have been the hardest-hit sectors, but have improved over the past two months as governments have loosened up on some of the harshest restrictions on activity.</p><p>At the same time, manufacturing is enjoying a boom, with an Institute for Supply Management gauge of activity in the sector hitting its highest level since late 1983 in March.</p><p>The pace of gains combined with the unprecedented level of government stimulus has kindled worries about inflation, though Federal Reserve officials say any increases will be temporary.</p><p>The Fed is keeping a close eye on the jobs data, but policymakers have said repeatedly that even with the recent improvements the labor market is nowhere near a point that would push the central bank into raising interest rates.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1176602902","content_text":"(April 2) Job growth boomed in March at the fastest pace since last summer as stronger economic growth and an aggressive vaccination effort pushed companies to step up hiring, the Labor Department reported Friday.Nonfarm payrolls increased by 916,000 for the month while the unemployment rate fell to 6%.Economists surveyed by Dow Jones had been looking for an increase of 675,000 and an unemployment rate of 6%.The report comes amid a slew of other indicators pointing to stronger growth as the U.S. tries to shake off the effects of the Covid-19 pandemic. States and municipalities across the country continue to reopen after a year of operating at reduced capacity.Business activity has returned to close to normal levels in much of the company despite the restrictions, with a tracker by Jeffries indicating that activity is at 93.5% of its pre-pandemic level.Data from Homebase shows that employees working and hours worked both gained sharply over the past month, with significant improvements in both hospitality and entertainment. Those have been the hardest-hit sectors, but have improved over the past two months as governments have loosened up on some of the harshest restrictions on activity.At the same time, manufacturing is enjoying a boom, with an Institute for Supply Management gauge of activity in the sector hitting its highest level since late 1983 in March.The pace of gains combined with the unprecedented level of government stimulus has kindled worries about inflation, though Federal Reserve officials say any increases will be temporary.The Fed is keeping a close eye on the jobs data, but policymakers have said repeatedly that even with the recent improvements the labor market is nowhere near a point that would push the central bank into raising interest rates.","news_type":1},"isVote":1,"tweetType":1,"viewCount":242,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":325896513,"gmtCreate":1615883992132,"gmtModify":1704787885492,"author":{"id":"3574123214878817","authorId":"3574123214878817","name":"KP1331","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574123214878817","authorIdStr":"3574123214878817"},"themes":[],"htmlText":"Cool&nbsp;","listText":"Cool&nbsp;","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/325896513","repostId":"1158082879","repostType":4,"repost":{"id":"1158082879","kind":"news","pubTimestamp":1615882597,"share":"https://ttm.financial/m/news/1158082879?lang=&edition=fundamental","pubTime":"2021-03-16 16:16","market":"us","language":"en","title":"Stripe now most valuable US startup","url":"https://stock-news.laohu8.com/highlight/detail?id=1158082879","media":"foxbusiness","summary":"Stripe Inc. is the most valuable U.S. startup after securing a $600 million round of funding.The San","content":"<p>Stripe Inc. is the most valuable U.S. startup after securing a $600 million round of funding.</p><p>The San Francisco and Dublin-based online payments technology provider is now valued at $95 billion, nearly three times the $36 billion valuation that it was awarded in April 2020.</p><p>Stripe plans to use the funds to invest in its European operations, in particular its Dublin headquarters, to support growing demand from the region and to expand its global payments and treasury network. Nearly 75% of the 42 countries that use Stripe are located in Europe, including many of the continent’s fastest-growing companies.</p><p>Primary investors in the funding round include Ireland’s National Treasury Management Agency, insurers Allianz and AXA SA, investment managers Baillie Gifford and Fidelity Investments, venture capital firm Sequoia Capital.</p><p>Stripe now trails only China’s Bytedance ($140 billion) as the world’s most valuable startup, according toCB Insights. It is ahead of Elon Musk’s SpaceX ($74 billion) and Instacart Inc. ($39 billion) as the largest U.S. startup.</p><p>Stripe has experienced tremendous growth over the past year as many of its customers benefitted from the online shopping boom that occurred as a result of the COVID-19 pandemic. Customers include Amazon Inc., Wayfair Inc. and Shopify Inc.</p><p>Stripe will soon be available in Brazil, India, Indonesia, Thailand and the United Arab Emirates. The company says its mission is to grow the GDP of the internet, which accounts for 14% of commerce.</p><p>“The pandemic taught us many things about society, including how much can be achieved — and paid for — online, but the internet still isn’t the engine for global economic progress that it could be,” CFO Dhivya Suryadevara said in a statement.</p>","source":"lsy1610518597439","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stripe now most valuable US startup</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStripe now most valuable US startup\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-16 16:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.foxbusiness.com/markets/stripe-now-most-valuable-us-startup><strong>foxbusiness</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stripe Inc. is the most valuable U.S. startup after securing a $600 million round of funding.The San Francisco and Dublin-based online payments technology provider is now valued at $95 billion, nearly...</p>\n\n<a href=\"https://www.foxbusiness.com/markets/stripe-now-most-valuable-us-startup\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.foxbusiness.com/markets/stripe-now-most-valuable-us-startup","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1158082879","content_text":"Stripe Inc. is the most valuable U.S. startup after securing a $600 million round of funding.The San Francisco and Dublin-based online payments technology provider is now valued at $95 billion, nearly three times the $36 billion valuation that it was awarded in April 2020.Stripe plans to use the funds to invest in its European operations, in particular its Dublin headquarters, to support growing demand from the region and to expand its global payments and treasury network. Nearly 75% of the 42 countries that use Stripe are located in Europe, including many of the continent’s fastest-growing companies.Primary investors in the funding round include Ireland’s National Treasury Management Agency, insurers Allianz and AXA SA, investment managers Baillie Gifford and Fidelity Investments, venture capital firm Sequoia Capital.Stripe now trails only China’s Bytedance ($140 billion) as the world’s most valuable startup, according toCB Insights. It is ahead of Elon Musk’s SpaceX ($74 billion) and Instacart Inc. ($39 billion) as the largest U.S. startup.Stripe has experienced tremendous growth over the past year as many of its customers benefitted from the online shopping boom that occurred as a result of the COVID-19 pandemic. Customers include Amazon Inc., Wayfair Inc. and Shopify Inc.Stripe will soon be available in Brazil, India, Indonesia, Thailand and the United Arab Emirates. The company says its mission is to grow the GDP of the internet, which accounts for 14% of commerce.“The pandemic taught us many things about society, including how much can be achieved — and paid for — online, but the internet still isn’t the engine for global economic progress that it could be,” CFO Dhivya Suryadevara said in a statement.","news_type":1},"isVote":1,"tweetType":1,"viewCount":580,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320774966,"gmtCreate":1615183917755,"gmtModify":1704779225111,"author":{"id":"3574123214878817","authorId":"3574123214878817","name":"KP1331","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574123214878817","authorIdStr":"3574123214878817"},"themes":[],"htmlText":"Buy the dip!!","listText":"Buy the dip!!","text":"Buy the dip!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/320774966","repostId":"1174323549","repostType":4,"repost":{"id":"1174323549","kind":"news","pubTimestamp":1615182391,"share":"https://ttm.financial/m/news/1174323549?lang=&edition=fundamental","pubTime":"2021-03-08 13:46","market":"us","language":"en","title":"A Stock Market Crash May Be Coming: 6 Metrics You'll Want to Know","url":"https://stock-news.laohu8.com/highlight/detail?id=1174323549","media":"Motley Fool","summary":"Over the past three weeks, the stock market has sent investors a stern warning: Equities can go down","content":"<p>Over the past three weeks, the stock market has sent investors a stern warning: Equities can go down, too.</p>\n<p>Despite the benchmark<b>S&amp;P 500</b>(SNPINDEX:^GSPC), iconic<b>Dow Jones Industrial Average</b>(DJINDICES:^DJI), and growth-oriented<b>Nasdaq Composite</b>(NASDAQINDEX:^IXIC)reveling in record-breaking bounce-back rallies from the March 23, 2020, bear market low, the conditions areripe for a stock market crash.</p>\n<p>Since emotion is the primary driver of very short-term price movements, we're never going to know precisely when a crash or correction is coming. But make no mistake about it, crashes and corrections are an inevitable part of the investing cycle, and some would say the price of admission to the greatest wealth-creating tool on the planet.</p>\n<p>With this in mind, here are six stock market crash metrics every investor should have in mind.</p>\n<p><b>1. A Shiller P/E greater than 30 leads to a bear market, historically</b></p>\n<p>As noted, the market doesn't often give us telltale signs that a crash is coming. One of the very few indicators that, thus far, has apretty immaculate track record of calling crashesis the Shiller S&amp;P 500 price-to-earnings (P/E) ratio. It's a P/E ratio based on inflation-adjusted earnings from the previous 10 years.</p>\n<p>Over the past 150 years, the average Shiller P/E reading is 16.79. As of March 3, 2021, the Shiller P/E stood at 34.59 --more than double the historic average.</p>\n<p>Here's where it gets interesting. There have been only five bull market rallies in history where the Shiller P/E for the S&amp;P 500 surpassed 30 and held for a period of time. A few of these periods might ring a bell, such as the Great Depression, the dot-com bubble, and the coronavirus crash. Admittedly, the March 2020 crash had nothing to do with valuations and was purely a response to a once-in-a-generation pandemic. Nevertheless, it doesn't change the fact that the four previous instances of the Shiller P/E surpassing 30 have led to declines in the S&amp;P 500 ranging between 20% and 89%.</p>\n<p>In other words, history suggests that when the Shiller P/E heads above 30, a decline or a full-on bear market soon follows.</p>\n<p><b>2. Corrections occur every 1.87 years</b></p>\n<p>No matter what sort of decline awaits investors in the future, it's important to recognize just how common these downward moves in the stock market are.</p>\n<p>According to data from market analytics company Yardeni Research, there have been 38 declines of at least 10% in the widely followedS&amp;P 500since the beginning of 1950. Over this 71-year span, we're talking about a double-digit decline every 1.87 years, on average.</p>\n<p>Keep in mind that averages are exactly that -- averages. There have been long periods in which corrections were few and far between. For example, there wasn't a single double-digit crash or correction between 1991 and 1996. By comparison, there have been seven double-digit percentage declines in the past 11 years, with at least eight other drops ranging from 5.8% to 9.9%.</p>\n<p>Corrections are a healthy and normal occurrence.</p>\n<p><b>3. The average correction is six months long</b></p>\n<p>Although corrections tend to bum out optimists, here's some good news: Most crashes and corrections don't last very long.</p>\n<p>Dating back to 1950, 24 of the S&amp;P 500's 38 double-digit percentage corrections have found their bottom in 104 or fewer calendar days (about 3.5 months). It took another seven between 157 and 288 calendar days to hit their trough. This means only seven significant declines in the market lasted longer than a year over the past seven-plus decades.</p>\n<p>When we add those up, the S&amp;P 500 has spent 7,168 days in correction since 1950. This works out to an average correction length of 188 days, orjust over six months. Compare this figure to the 11-year bull market we just exited, and you can see why it pays to be an optimist.</p>\n<p><b>4. Modern-era corrections are a month shorter, on average</b></p>\n<p>Cue the \"but wait -- there's more\" music.</p>\n<p>Even though corrections and crashes have been relatively short-lived over the past 71 years, they're even shorter in the modern era. I'm defining \"modern era\" as the rise of computers, which have assisted immensely with trading and providing supply-demand balance to equities. I'm arbitrarily using 1985 as the beginning of this modern era.</p>\n<p>Since 1985, the S&amp;P 500 has undergone 16 double-digit declines. These include the dot-com bubble, which at 929 calendar days is the longest decline in the benchmark index's history. Even with this outlier, the average length of a crash or correction in the modern era is only 155 days. That's a full month shorter than the historical average for the broad-based index.</p>\n<p>With the internet giving retail investors instant access to information, the barriers that once existed between Wall Street and Main Streethave been torn down. This has played a key role in shortening the length of corrections and crashes.</p>\n<p><b>5. 70% of the market's worst days are followed by its best gains</b></p>\n<p>Another interesting statistic that's bound to raise an eyebrow or two is the correlation between the stock market's best and worst days. While some folks might be tempted to run for cover at the first sign of trouble, history shows that this isthe worst possible thing to do.</p>\n<p>Last year, J.P. Morgan Asset Management released what's become an annual report that examines the rolling 20-year returns of the S&amp;P 500. In particular, J.P. Morgan Asset Management looked at how investors' returns would differ if they missed only a handful of the market's best days over a 20-year period. Between Jan. 3, 2000, and Dec. 31, 2019, missing just the 20 best days would have effectively wiped out a 6% annual average return.</p>\n<p>But what really stands out is how close the S&amp;P 500's best and worst days occur to each other. According to the \"Impact of Being Out of the Market\" report, from Jan. 3, 2000, through April 19, 2020, \"Seven of the ten worst days were followed the NEXT DAY [emphasis by J.P. Morgan Asset Management] by either top 10 returns over the 20 years or top 10 returns for their respective years.\"</p>\n<p>If you try to game the market, you're the one that gets played.</p>\n<p><b>6. Long-term investors are batting 1.000</b></p>\n<p>I saved thebest stock market crash metric for last.</p>\n<p>A bull market rally has eventually put each and every one of these 38 declines in the rearview mirror. And in many instances, it took just weeks or months to erase the declines. For practical purposes, it doesn't matter when you buy during a correction or crash. As long as you buy stakes in an assortment of high-quality, innovative businesses, and you hold those stocks for long periods of time, you have an exceptionally good chance of making money.</p>\n<p>If you need further proof, data from Crestmont Research on the S&amp;P 500 shows thatat no pointbetween 1919 and 2019 have rolling 20-year returns on the index ever been negative. In fact, only two ending years out of this 101-year period yielded average annual total returns (that is, including dividends) of less than 5%. If you buy with the intent of holding for a really long time, historical data suggests you're going to do very well.</p>\n<p><b>10 stocks that could be the biggest winners of the stock market crash</b></p>\n<p>When investing geniuses David and Tom Gardner have an investing tip, it can pay to listen. After all, the newsletter they have run for over a decade,<i>Motley Fool Stock Advisor</i>, has quadrupled the market.*</p>\n<p>David and Tom just revealed what they believe are the<b>ten best buys</b>for investors right now… And while timing isn't everything, the history of Tom and David's stock picks shows that it pays to get in early on their best ideas.</p>\n<p></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Stock Market Crash May Be Coming: 6 Metrics You'll Want to Know</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Stock Market Crash May Be Coming: 6 Metrics You'll Want to Know\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-08 13:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/03/07/stock-market-crash-coming-6-metrics-want-to-know/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Over the past three weeks, the stock market has sent investors a stern warning: Equities can go down, too.\nDespite the benchmarkS&P 500(SNPINDEX:^GSPC), iconicDow Jones Industrial Average(DJINDICES:^...</p>\n\n<a href=\"https://www.fool.com/investing/2021/03/07/stock-market-crash-coming-6-metrics-want-to-know/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/03/07/stock-market-crash-coming-6-metrics-want-to-know/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1174323549","content_text":"Over the past three weeks, the stock market has sent investors a stern warning: Equities can go down, too.\nDespite the benchmarkS&P 500(SNPINDEX:^GSPC), iconicDow Jones Industrial Average(DJINDICES:^DJI), and growth-orientedNasdaq Composite(NASDAQINDEX:^IXIC)reveling in record-breaking bounce-back rallies from the March 23, 2020, bear market low, the conditions areripe for a stock market crash.\nSince emotion is the primary driver of very short-term price movements, we're never going to know precisely when a crash or correction is coming. But make no mistake about it, crashes and corrections are an inevitable part of the investing cycle, and some would say the price of admission to the greatest wealth-creating tool on the planet.\nWith this in mind, here are six stock market crash metrics every investor should have in mind.\n1. A Shiller P/E greater than 30 leads to a bear market, historically\nAs noted, the market doesn't often give us telltale signs that a crash is coming. One of the very few indicators that, thus far, has apretty immaculate track record of calling crashesis the Shiller S&P 500 price-to-earnings (P/E) ratio. It's a P/E ratio based on inflation-adjusted earnings from the previous 10 years.\nOver the past 150 years, the average Shiller P/E reading is 16.79. As of March 3, 2021, the Shiller P/E stood at 34.59 --more than double the historic average.\nHere's where it gets interesting. There have been only five bull market rallies in history where the Shiller P/E for the S&P 500 surpassed 30 and held for a period of time. A few of these periods might ring a bell, such as the Great Depression, the dot-com bubble, and the coronavirus crash. Admittedly, the March 2020 crash had nothing to do with valuations and was purely a response to a once-in-a-generation pandemic. Nevertheless, it doesn't change the fact that the four previous instances of the Shiller P/E surpassing 30 have led to declines in the S&P 500 ranging between 20% and 89%.\nIn other words, history suggests that when the Shiller P/E heads above 30, a decline or a full-on bear market soon follows.\n2. Corrections occur every 1.87 years\nNo matter what sort of decline awaits investors in the future, it's important to recognize just how common these downward moves in the stock market are.\nAccording to data from market analytics company Yardeni Research, there have been 38 declines of at least 10% in the widely followedS&P 500since the beginning of 1950. Over this 71-year span, we're talking about a double-digit decline every 1.87 years, on average.\nKeep in mind that averages are exactly that -- averages. There have been long periods in which corrections were few and far between. For example, there wasn't a single double-digit crash or correction between 1991 and 1996. By comparison, there have been seven double-digit percentage declines in the past 11 years, with at least eight other drops ranging from 5.8% to 9.9%.\nCorrections are a healthy and normal occurrence.\n3. The average correction is six months long\nAlthough corrections tend to bum out optimists, here's some good news: Most crashes and corrections don't last very long.\nDating back to 1950, 24 of the S&P 500's 38 double-digit percentage corrections have found their bottom in 104 or fewer calendar days (about 3.5 months). It took another seven between 157 and 288 calendar days to hit their trough. This means only seven significant declines in the market lasted longer than a year over the past seven-plus decades.\nWhen we add those up, the S&P 500 has spent 7,168 days in correction since 1950. This works out to an average correction length of 188 days, orjust over six months. Compare this figure to the 11-year bull market we just exited, and you can see why it pays to be an optimist.\n4. Modern-era corrections are a month shorter, on average\nCue the \"but wait -- there's more\" music.\nEven though corrections and crashes have been relatively short-lived over the past 71 years, they're even shorter in the modern era. I'm defining \"modern era\" as the rise of computers, which have assisted immensely with trading and providing supply-demand balance to equities. I'm arbitrarily using 1985 as the beginning of this modern era.\nSince 1985, the S&P 500 has undergone 16 double-digit declines. These include the dot-com bubble, which at 929 calendar days is the longest decline in the benchmark index's history. Even with this outlier, the average length of a crash or correction in the modern era is only 155 days. That's a full month shorter than the historical average for the broad-based index.\nWith the internet giving retail investors instant access to information, the barriers that once existed between Wall Street and Main Streethave been torn down. This has played a key role in shortening the length of corrections and crashes.\n5. 70% of the market's worst days are followed by its best gains\nAnother interesting statistic that's bound to raise an eyebrow or two is the correlation between the stock market's best and worst days. While some folks might be tempted to run for cover at the first sign of trouble, history shows that this isthe worst possible thing to do.\nLast year, J.P. Morgan Asset Management released what's become an annual report that examines the rolling 20-year returns of the S&P 500. In particular, J.P. Morgan Asset Management looked at how investors' returns would differ if they missed only a handful of the market's best days over a 20-year period. Between Jan. 3, 2000, and Dec. 31, 2019, missing just the 20 best days would have effectively wiped out a 6% annual average return.\nBut what really stands out is how close the S&P 500's best and worst days occur to each other. According to the \"Impact of Being Out of the Market\" report, from Jan. 3, 2000, through April 19, 2020, \"Seven of the ten worst days were followed the NEXT DAY [emphasis by J.P. Morgan Asset Management] by either top 10 returns over the 20 years or top 10 returns for their respective years.\"\nIf you try to game the market, you're the one that gets played.\n6. Long-term investors are batting 1.000\nI saved thebest stock market crash metric for last.\nA bull market rally has eventually put each and every one of these 38 declines in the rearview mirror. And in many instances, it took just weeks or months to erase the declines. For practical purposes, it doesn't matter when you buy during a correction or crash. As long as you buy stakes in an assortment of high-quality, innovative businesses, and you hold those stocks for long periods of time, you have an exceptionally good chance of making money.\nIf you need further proof, data from Crestmont Research on the S&P 500 shows thatat no pointbetween 1919 and 2019 have rolling 20-year returns on the index ever been negative. In fact, only two ending years out of this 101-year period yielded average annual total returns (that is, including dividends) of less than 5%. If you buy with the intent of holding for a really long time, historical data suggests you're going to do very well.\n10 stocks that could be the biggest winners of the stock market crash\nWhen investing geniuses David and Tom Gardner have an investing tip, it can pay to listen. After all, the newsletter they have run for over a decade,Motley Fool Stock Advisor, has quadrupled the market.*\nDavid and Tom just revealed what they believe are theten best buysfor investors right now… And while timing isn't everything, the history of Tom and David's stock picks shows that it pays to get in early on their best ideas.","news_type":1},"isVote":1,"tweetType":1,"viewCount":297,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":367072423,"gmtCreate":1614900106462,"gmtModify":1704776680523,"author":{"id":"3574123214878817","authorId":"3574123214878817","name":"KP1331","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574123214878817","authorIdStr":"3574123214878817"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/367072423","repostId":"1178192831","repostType":4,"repost":{"id":"1178192831","kind":"news","pubTimestamp":1614871669,"share":"https://ttm.financial/m/news/1178192831?lang=&edition=fundamental","pubTime":"2021-03-04 23:27","market":"us","language":"en","title":"GM evaluating second U.S. battery plant for EVs amid construction of $2.3 billion facility in Ohio","url":"https://stock-news.laohu8.com/highlight/detail?id=1178192831","media":"cnbc","summary":"KEY POINTS\n\nGM is evaluating a second location in the U.S. to produce battery cells for electric veh","content":"<div>\n<p>KEY POINTS\n\nGM is evaluating a second location in the U.S. to produce battery cells for electric vehicles with LG Chem.\nThrough their Ultium Cells LLC joint venture, the companies are currently ...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/04/gm-considering-second-ev-battery-plant-in-the-us.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GM evaluating second U.S. battery plant for EVs amid construction of $2.3 billion facility in Ohio</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGM evaluating second U.S. battery plant for EVs amid construction of $2.3 billion facility in Ohio\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-04 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/03/04/gm-considering-second-ev-battery-plant-in-the-us.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KEY POINTS\n\nGM is evaluating a second location in the U.S. to produce battery cells for electric vehicles with LG Chem.\nThrough their Ultium Cells LLC joint venture, the companies are currently ...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/04/gm-considering-second-ev-battery-plant-in-the-us.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GM":"通用汽车"},"source_url":"https://www.cnbc.com/2021/03/04/gm-considering-second-ev-battery-plant-in-the-us.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1178192831","content_text":"KEY POINTS\n\nGM is evaluating a second location in the U.S. to produce battery cells for electric vehicles with LG Chem.\nThrough their Ultium Cells LLC joint venture, the companies are currently spending $2.3 billion for a new battery cell plant in Ohio.\nGM said it hopes “to have a decision on the potential project” by June.\n\nGeneral Motorsis looking at building a second plant in the U.S. to produce battery cells for electric vehicles through a joint venture withLG Chem.\nThe automaker confirmed the plans Thursday morning after theWall Street Journal reportedthe companies were close to a decision to locate the plant in Tennessee, but a final selection hadn’t been made. GM said it hopes “to have a decision on the potential project” by June.\nThrough their Ultium Cells LLC joint venture, GM and LG are currentlyspending $2.3 billionfor a new battery cell plant in Ohio. The plant is expected to be completed in 2022, allowing the automaker to lower costs and bring vehicles to market more quickly. The plant is considered a lynchpin to GM’s plans for its next-generation EVs to be profitable.\nGM is expected to release 20 new or redesigned EVs as part of its$27 billion investmentplan from 2020 through 2025.\nUltium is GM’snext-generation batteriesand platform, which is expected to debut later this year in the GMC Hummer EV pickup. The first vehicles are not expected to include Ultium battery cells from the plant that’s currently under construction.\nOutgoing GM Chief Sustainability Officer Dane Parker last year said the automaker would need to make more investment in battery production capacity. He said the increase would likely be a mix of new facilities and retrofitting existing plants.\n“We’re able to, in many cases, retrofit existing propulsion plants to do that,” he said during a Goldman Sachs conference in December. “In some cases, we’ll be building new ones.”\nAmid anongoing semiconductor chip shortagethat’s impacting vehicle production globally, there has been a growing interest in restructuring vehicle supply chains, specifically for higher tech components, including battery cells. The White House last week ordered a review of the U.S. battery supply chain.\n“We need to bring battery production to the U.S.,” Ford CEO Jim Farley said last month during a Wolfe Research conference. “We can’t go through what we’re doing with chips right now in Taiwan. It’s just important.”\nFord has not announced any plans for investing in U.S. battery production. Most batteries currently are manufactured in Asia and Europe.Teslacurrently operates a massive battery and cell manufacturing facility with panasonic in Nevada. Tesla also told investors in September that it started producing its own cells at a pilot plant in Fremont, California.","news_type":1},"isVote":1,"tweetType":1,"viewCount":169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":364600766,"gmtCreate":1614841855455,"gmtModify":1704775882873,"author":{"id":"3574123214878817","authorId":"3574123214878817","name":"KP1331","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574123214878817","authorIdStr":"3574123214878817"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/364600766","repostId":"1195543456","repostType":4,"isVote":1,"tweetType":1,"viewCount":251,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":365260620,"gmtCreate":1614746716260,"gmtModify":1704774723999,"author":{"id":"3574123214878817","authorId":"3574123214878817","name":"KP1331","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574123214878817","authorIdStr":"3574123214878817"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/365260620","repostId":"1178860453","repostType":4,"repost":{"id":"1178860453","kind":"news","pubTimestamp":1614737603,"share":"https://ttm.financial/m/news/1178860453?lang=&edition=fundamental","pubTime":"2021-03-03 10:13","market":"hk","language":"en","title":"Ting Hsin Weighing $800 Million IPO of KFC’s Chinese Rival","url":"https://stock-news.laohu8.com/highlight/detail?id=1178860453","media":"Bloomberg","summary":"(Bloomberg) -- Ting Hsin International Group, the Taiwanese food company behind the Master Kong bran","content":"<p>(Bloomberg) -- Ting Hsin International Group, the Taiwanese food company behind the Master Kong brand, is weighing a Hong Kong initial public offering of its restaurant business in mainland China, people with knowledge of the matter said.</p>\n<p>The firm has invited banks to pitch for a role on the listing, said the people, who asked not to be identified as the information is private. The Taiwanese company may include restaurant chains Dicos, a prominent fried chicken brand, and Master Kong Chef’s Table, which specializes in Taiwan-style beef noodles, in the Hong Kong listing, the people said. The IPO could raise about $800 million, one of the people said.</p>\n<p>Deliberations are at an early stage and the company may decide not to pursue an IPO, the people said. A representative for Ting Hsin couldn’t immediately comment.</p>\n<p>Dicos operates about 2,600 outlets across China and has more than 70,000 employees serving 600 million customers annually, according to a press release. It announced in January that it has added plant-based egg substitute JUST Egg to its menu at over 500 locations in China.</p>\n<p>The chain ranks third in China by market share among limited service restaurants, which comprise fast food and fully-takeaway outlets, according to market research provider Euromonitor International. Dicos’ 1.2% share puts it behind only Yum China Holdings Inc.’s KFC and McDonald’s Corp. in the country.</p>\n<p>Ting Hsin is a major shareholder in Tingyi (Cayman Island) Holding Corp., a Hong Kong-listed firm that sells Master Kong-branded noodles, teas and juices, and which is PepsiCo Inc.’s official partner in China.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ting Hsin Weighing $800 Million IPO of KFC’s Chinese Rival</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTing Hsin Weighing $800 Million IPO of KFC’s Chinese Rival\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-03 10:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/ting-hsin-weighing-800-million-100152657.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Ting Hsin International Group, the Taiwanese food company behind the Master Kong brand, is weighing a Hong Kong initial public offering of its restaurant business in mainland China, ...</p>\n\n<a href=\"https://finance.yahoo.com/news/ting-hsin-weighing-800-million-100152657.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://finance.yahoo.com/news/ting-hsin-weighing-800-million-100152657.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178860453","content_text":"(Bloomberg) -- Ting Hsin International Group, the Taiwanese food company behind the Master Kong brand, is weighing a Hong Kong initial public offering of its restaurant business in mainland China, people with knowledge of the matter said.\nThe firm has invited banks to pitch for a role on the listing, said the people, who asked not to be identified as the information is private. The Taiwanese company may include restaurant chains Dicos, a prominent fried chicken brand, and Master Kong Chef’s Table, which specializes in Taiwan-style beef noodles, in the Hong Kong listing, the people said. The IPO could raise about $800 million, one of the people said.\nDeliberations are at an early stage and the company may decide not to pursue an IPO, the people said. A representative for Ting Hsin couldn’t immediately comment.\nDicos operates about 2,600 outlets across China and has more than 70,000 employees serving 600 million customers annually, according to a press release. It announced in January that it has added plant-based egg substitute JUST Egg to its menu at over 500 locations in China.\nThe chain ranks third in China by market share among limited service restaurants, which comprise fast food and fully-takeaway outlets, according to market research provider Euromonitor International. Dicos’ 1.2% share puts it behind only Yum China Holdings Inc.’s KFC and McDonald’s Corp. in the country.\nTing Hsin is a major shareholder in Tingyi (Cayman Island) Holding Corp., a Hong Kong-listed firm that sells Master Kong-branded noodles, teas and juices, and which is PepsiCo Inc.’s official partner in China.","news_type":1},"isVote":1,"tweetType":1,"viewCount":394,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":362598167,"gmtCreate":1614647244259,"gmtModify":1704773461966,"author":{"id":"3574123214878817","authorId":"3574123214878817","name":"KP1331","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574123214878817","authorIdStr":"3574123214878817"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/362598167","repostId":"1143415407","repostType":4,"repost":{"id":"1143415407","kind":"news","pubTimestamp":1614608364,"share":"https://ttm.financial/m/news/1143415407?lang=&edition=fundamental","pubTime":"2021-03-01 22:19","market":"us","language":"en","title":"Is AMD Stock A Buy After Chipmaker's Fourth-Quarter Earnings Report?","url":"https://stock-news.laohu8.com/highlight/detail?id=1143415407","media":"Investors","summary":"Advanced Micro Devices(AMD) stock is down since the chipmaker reported fourth-quarter results in lat","content":"<p><b>Advanced Micro Devices</b>(AMD) stock is down since the chipmaker reported fourth-quarter results in late January. With a pullback in shares, some investors may be wondering: Is AMD stock a buy right now?</p>\n<p>AMD has staged an amazing turnaround over the past five years, fueled by new products and improved profitability. And AMD stock has climbed as a result.</p>\n<p>AMD competes with<b>Intel</b>(INTC) in making central processing units, or CPUs, for personal computers and servers. It also rivals<b>Nvidia</b>(NVDA) in the market for graphics processing units, or GPUs, for PCs, gaming consoles and data centers.</p>\n<p>Founded in May 1969, AMD went&nbsp;public in September 1972.&nbsp;AMD shifted to a fabless semiconductor business in March 2009 by spinning off its factories into a joint venture called GlobalFoundries.</p>\n<p><b>Chief Executive Lisa Su Making A Difference</b></p>\n<p>Current Chief Executive Lisa Su took the reins in October 2014. She shepherded the Santa Clara, Calif.-based company into a new era with its Ryzen PC processors and Epyc server chips in 2017.</p>\n<p>Under her supervision, AMD jumped ahead of Intel in making CPUs at smaller node sizes, giving its products an edge in speed and performance. AMD is making chips at 7-nanometer scale, while Intel has struggled to make chips at 10-nanometer scale. AMD is now developing chips at 5-nanometer scale. Circuit widths on chips are measured in nanometers, which are one-billionth of a meter.</p>\n<p>On July 23,Intel announced a six-month delayin production of its already behind-schedule 7-nanometer processors. Intel now expects to ship its first 7-nanometer processors in late 2022 or early 2023. By that time, AMD could be making 3-nanometer processors, analysts said.</p>\n<p>The situation has helped AMD take market share from Intel in PCs and servers. Those gains have buoyed AMD stock.</p>\n<p>Chip foundry&nbsp;<b>Taiwan Semiconductor Manufacturing</b>(TSM) produces AMD's chips.</p>\n<p>Su also is overseeing a potentially transformative acquisition. On Oct. 27, AMD announced an all-stock deal worth $35 billion to buy<b>Xilinx</b>(XLNX) to expand its growing data-center business. However, AMD stock fell on theXilinx acquisition news. Critics said the acquisition complicates AMD's \"clean\" investor story around market share gains in processors.</p>\n<p><b>Intel Losing Market Share To AMD</b></p>\n<p>In the fourth quarter, Intel regained market share from AMD in CPUs for desktop and notebook PCs, according to Mercury Research. That ended a three-year streak of market share gains by AMD in the PC segment on a quarter-to-quarter basis. AMD also suffered supply constraints with its contract manufacturer in the period.</p>\n<p>AMD's unit share of desktop PC processor sales was 19.3% in the fourth quarter, down from 20.1% in the third quarter. However, it was up from 18.3% in the year-earlier period.</p>\n<p>AMD's unit share of notebook PC processor sales was 19% in the December quarter, down from 20.2% in the September quarter. But it was up from 16.2% in the year-earlier period.</p>\n<p>However, AMD continued to gain share in CPUs for servers during the fourth quarter. Its server CPU market share was 7.1% in the December quarter. That compares with 6.6% in the September quarter and 4.5% in the year-earlier quarter, Mercury said.</p>\n<p><b>Advanced Micro Devices News: New PC, Gaming Chips</b></p>\n<p>On Oct. 8, AMD introduced its next-generation Ryzen processors for desktop computers. It described itsRyzen 5000 series central processing unitsas the \"fastest gaming CPUs in the world.\"&nbsp;The Ryzen 5000 series products are aimed at PC gamers and content creators.</p>\n<p>On Jan. 12, during a keynote speech at the virtual CES 2021 tech conference, Chief Executive Su introduced the company's newRyzen 5000 Series mobile processors. She called the chips \"the most powerful PC processors ever built for ultrathin and gaming notebooks.\" However, AMD stock fell 2% that day.</p>\n<p>The next potential catalyst for AMD stock will be March 3. On that date, AMD plans to introduce the newest addition to its Radeon RX family of high-performance graphic cards.</p>\n<p><b>AMD Fundamental Analysis</b></p>\n<p><img src=\"https://static.tigerbbs.com/9c60b5a17f32fbcdbeaf44cd79b85591\" tg-width=\"818\" tg-height=\"418\">Late Jan. 26,AMD reported better-than-expected fourth-quarter results, thanks to strong demand for PC, gaming and data center products. But AMD stock fell 6.2% the next day.</p>\n<p>AMD earned an adjusted 52 cents a share on sales of $3.24 billion in the December quarter. Analysts expected AMD earnings of 47 cents a share on sales of $3.02 billion. On a year-over-year basis, AMD earnings rose 63% while sales climbed 53%.</p>\n<p>For the current quarter, AMD expects to generate revenue of $3.2 billion, up 79% from the year-earlier period. Wall Street analysts predicted AMD sales of $2.73 billion in the first quarter.</p>\n<p>For the full year, AMD expects sales to rise 37% to $13.38 billion. Analysts had been looking for 2021 revenue of $12.24 billion.</p>\n<p>At least six Wall Street analysts raised their price targets on AMD stock after the company's earnings report.</p>\n<p><b>AMD Stock Technical Analysis</b></p>\n<p>AMD stock sank to a nearly four-decade low of 1.61 a share in July 2015 before starting its epic recovery.</p>\n<p>On Nov. 30, AMD stock broke out of a fourth-stage,double-bottom basewith abuy pointof 88.82, according toIBD MarketSmithcharts. It notched a record high of 99.23 on Jan. 11.</p>\n<p>For two months after itsbreakout, AMD stock traded in and out of the5% chase zone. However, it triggered around-trip sell signalafter retreating from a breakout gain of more than 10% back to below the buy point.</p>\n<p>AMD stock flashed anothersell signalon Feb. 23 when it dropped 7% to 8% below the buy point of its breakout. It ended the regular session Feb. 26 in the sell zone at 84.51.</p>\n<p>AMD stock has anIBD Relative Strength Ratingof 62. That means it has outperformed 62% of stocks on the market over the past 12 months. The best growth stocks typically have RS Ratings of at least 80. And AMD'srelative strength linehas declined since mid-December as it underperforms the S&amp;P 500 index.</p>\n<p>It has anIBD Accumulation/Distribution Ratingof B-, indicating some institutional buying of AMD shares.</p>\n<p>AMD stock is on theIBD 50&nbsp;listof top-performing growth stocks.</p>\n<p><b>Is AMD Stock A Buy Right Now?</b></p>\n<p>AMD stock is not a buy right now. It is trading well below its50-day moving average line, a negative sign.</p>\n<p>AMD stock will need to form anew basein theright market conditionsbefore setting a new potential buy point. Check outIBD's Big Picture columnfor the current market direction.</p>\n<p>AMD stock has anIBD Composite Ratingof 95 out of a best-possible 99. IBD's Composite Rating combines five separate proprietary ratings into one easy-to-use rating. The best growth stocks have a Composite Rating of 90 or better.</p>\n<p>TheIBD Stock Checkuptool ranks AMD in fourth place in IBD's fabless semiconductor industry group. So, there are better stocks in the group to consider.</p>\n<p>Also, the fabless chipmaker group ranks No. 88 out of 197 industry groups that IBD tracks. Growth stock investors should focus on leading stocks in the top 40 industry groups.</p>\n<p>To find thebest stocks to buy or watch, check outIBD Stock Listsas well as IBD'sLeaderboard,MarketSmithandSwingTraderplatforms.</p>","source":"lsy1610449120050","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is AMD Stock A Buy After Chipmaker's Fourth-Quarter Earnings Report?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs AMD Stock A Buy After Chipmaker's Fourth-Quarter Earnings Report?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-01 22:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investors.com/news/technology/amd-stock-buy-now/?src=A00220><strong>Investors</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Advanced Micro Devices(AMD) stock is down since the chipmaker reported fourth-quarter results in late January. With a pullback in shares, some investors may be wondering: Is AMD stock a buy right now?...</p>\n\n<a href=\"https://www.investors.com/news/technology/amd-stock-buy-now/?src=A00220\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMD":"美国超微公司"},"source_url":"https://www.investors.com/news/technology/amd-stock-buy-now/?src=A00220","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143415407","content_text":"Advanced Micro Devices(AMD) stock is down since the chipmaker reported fourth-quarter results in late January. With a pullback in shares, some investors may be wondering: Is AMD stock a buy right now?\nAMD has staged an amazing turnaround over the past five years, fueled by new products and improved profitability. And AMD stock has climbed as a result.\nAMD competes withIntel(INTC) in making central processing units, or CPUs, for personal computers and servers. It also rivalsNvidia(NVDA) in the market for graphics processing units, or GPUs, for PCs, gaming consoles and data centers.\nFounded in May 1969, AMD went public in September 1972. AMD shifted to a fabless semiconductor business in March 2009 by spinning off its factories into a joint venture called GlobalFoundries.\nChief Executive Lisa Su Making A Difference\nCurrent Chief Executive Lisa Su took the reins in October 2014. She shepherded the Santa Clara, Calif.-based company into a new era with its Ryzen PC processors and Epyc server chips in 2017.\nUnder her supervision, AMD jumped ahead of Intel in making CPUs at smaller node sizes, giving its products an edge in speed and performance. AMD is making chips at 7-nanometer scale, while Intel has struggled to make chips at 10-nanometer scale. AMD is now developing chips at 5-nanometer scale. Circuit widths on chips are measured in nanometers, which are one-billionth of a meter.\nOn July 23,Intel announced a six-month delayin production of its already behind-schedule 7-nanometer processors. Intel now expects to ship its first 7-nanometer processors in late 2022 or early 2023. By that time, AMD could be making 3-nanometer processors, analysts said.\nThe situation has helped AMD take market share from Intel in PCs and servers. Those gains have buoyed AMD stock.\nChip foundry Taiwan Semiconductor Manufacturing(TSM) produces AMD's chips.\nSu also is overseeing a potentially transformative acquisition. On Oct. 27, AMD announced an all-stock deal worth $35 billion to buyXilinx(XLNX) to expand its growing data-center business. However, AMD stock fell on theXilinx acquisition news. Critics said the acquisition complicates AMD's \"clean\" investor story around market share gains in processors.\nIntel Losing Market Share To AMD\nIn the fourth quarter, Intel regained market share from AMD in CPUs for desktop and notebook PCs, according to Mercury Research. That ended a three-year streak of market share gains by AMD in the PC segment on a quarter-to-quarter basis. AMD also suffered supply constraints with its contract manufacturer in the period.\nAMD's unit share of desktop PC processor sales was 19.3% in the fourth quarter, down from 20.1% in the third quarter. However, it was up from 18.3% in the year-earlier period.\nAMD's unit share of notebook PC processor sales was 19% in the December quarter, down from 20.2% in the September quarter. But it was up from 16.2% in the year-earlier period.\nHowever, AMD continued to gain share in CPUs for servers during the fourth quarter. Its server CPU market share was 7.1% in the December quarter. That compares with 6.6% in the September quarter and 4.5% in the year-earlier quarter, Mercury said.\nAdvanced Micro Devices News: New PC, Gaming Chips\nOn Oct. 8, AMD introduced its next-generation Ryzen processors for desktop computers. It described itsRyzen 5000 series central processing unitsas the \"fastest gaming CPUs in the world.\" The Ryzen 5000 series products are aimed at PC gamers and content creators.\nOn Jan. 12, during a keynote speech at the virtual CES 2021 tech conference, Chief Executive Su introduced the company's newRyzen 5000 Series mobile processors. She called the chips \"the most powerful PC processors ever built for ultrathin and gaming notebooks.\" However, AMD stock fell 2% that day.\nThe next potential catalyst for AMD stock will be March 3. On that date, AMD plans to introduce the newest addition to its Radeon RX family of high-performance graphic cards.\nAMD Fundamental Analysis\nLate Jan. 26,AMD reported better-than-expected fourth-quarter results, thanks to strong demand for PC, gaming and data center products. But AMD stock fell 6.2% the next day.\nAMD earned an adjusted 52 cents a share on sales of $3.24 billion in the December quarter. Analysts expected AMD earnings of 47 cents a share on sales of $3.02 billion. On a year-over-year basis, AMD earnings rose 63% while sales climbed 53%.\nFor the current quarter, AMD expects to generate revenue of $3.2 billion, up 79% from the year-earlier period. Wall Street analysts predicted AMD sales of $2.73 billion in the first quarter.\nFor the full year, AMD expects sales to rise 37% to $13.38 billion. Analysts had been looking for 2021 revenue of $12.24 billion.\nAt least six Wall Street analysts raised their price targets on AMD stock after the company's earnings report.\nAMD Stock Technical Analysis\nAMD stock sank to a nearly four-decade low of 1.61 a share in July 2015 before starting its epic recovery.\nOn Nov. 30, AMD stock broke out of a fourth-stage,double-bottom basewith abuy pointof 88.82, according toIBD MarketSmithcharts. It notched a record high of 99.23 on Jan. 11.\nFor two months after itsbreakout, AMD stock traded in and out of the5% chase zone. However, it triggered around-trip sell signalafter retreating from a breakout gain of more than 10% back to below the buy point.\nAMD stock flashed anothersell signalon Feb. 23 when it dropped 7% to 8% below the buy point of its breakout. It ended the regular session Feb. 26 in the sell zone at 84.51.\nAMD stock has anIBD Relative Strength Ratingof 62. That means it has outperformed 62% of stocks on the market over the past 12 months. The best growth stocks typically have RS Ratings of at least 80. And AMD'srelative strength linehas declined since mid-December as it underperforms the S&P 500 index.\nIt has anIBD Accumulation/Distribution Ratingof B-, indicating some institutional buying of AMD shares.\nAMD stock is on theIBD 50 listof top-performing growth stocks.\nIs AMD Stock A Buy Right Now?\nAMD stock is not a buy right now. It is trading well below its50-day moving average line, a negative sign.\nAMD stock will need to form anew basein theright market conditionsbefore setting a new potential buy point. Check outIBD's Big Picture columnfor the current market direction.\nAMD stock has anIBD Composite Ratingof 95 out of a best-possible 99. IBD's Composite Rating combines five separate proprietary ratings into one easy-to-use rating. The best growth stocks have a Composite Rating of 90 or better.\nTheIBD Stock Checkuptool ranks AMD in fourth place in IBD's fabless semiconductor industry group. So, there are better stocks in the group to consider.\nAlso, the fabless chipmaker group ranks No. 88 out of 197 industry groups that IBD tracks. Growth stock investors should focus on leading stocks in the top 40 industry groups.\nTo find thebest stocks to buy or watch, check outIBD Stock Listsas well as IBD'sLeaderboard,MarketSmithandSwingTraderplatforms.","news_type":1},"isVote":1,"tweetType":1,"viewCount":210,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":366740950,"gmtCreate":1614566981770,"gmtModify":1704772494210,"author":{"id":"3574123214878817","authorId":"3574123214878817","name":"KP1331","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574123214878817","authorIdStr":"3574123214878817"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/366740950","repostId":"2114432037","repostType":4,"repost":{"id":"2114432037","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1614317872,"share":"https://ttm.financial/m/news/2114432037?lang=&edition=fundamental","pubTime":"2021-02-26 13:37","market":"fut","language":"en","title":"Oil prices drop amid U.S. dollar strength, expectations for supply gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2114432037","media":"Reuters","summary":"SINGAPORE, Feb 26 (Reuters) - Oil prices dropped on Friday as a collapse in bond prices led to gains","content":"<p>SINGAPORE, Feb 26 (Reuters) - Oil prices dropped on Friday as a collapse in bond prices led to gains in the U.S. dollar and expectations grew that with oil prices back above pre-pandemic levels, more supply is likely to return to the market.</p>\n<p>U.S. West Texas Intermediate <a href=\"https://laohu8.com/S/WTI\">$(WTI)$</a> crude futures dropped 72 cents, or 1.1%, to $62.81 a barrel at 0516 GMT, giving up all of Thursday's gains.</p>\n<p>Brent crude futures for April, which expires on Friday, fell 63 cents, or 0.9%, to $66.25 a barrel, following a 16 cent loss on Thursday. The more active May contract was down 77 cents, or 1.2%, to $65.34 a barrel.</p>\n<p>\"Crude oil retreated modestly from recent highs amid a 'risk off' sentiment as Asia-Pacific equities pulled back broadly following a sour lead from Wall Street,\" said Margaret Yang, a strategist at Singapore-based DailyFX.</p>\n<p>The sell-off in bond markets, leading to a stronger U.S. dollar and rising yields, are weighing on commodities, which are non-yielding, she added.</p>\n<p>A stronger greenback makes U.S.-dollar priced oil more expensive for those buying crude in other currencies.</p>\n<p>Despite the drop in prices on Friday, both Brent and WTI are on track for gains of nearly 20% this month, as markets have grappled with supply disruptions in the United States, while optimism has built for demand to improve with vaccine rollouts.</p>\n<p>Investors are betting that next week's meeting of the Organization of the Petroleum Exporting Countries (OPEC) and allies, together called OPEC+, will result in more supply returning to the market.</p>\n<p>\"The stakes at play this time around are particularly large (for OPEC+) insofar as oil prices have more than recovered to pre-pandemic levels, global inventories are continuing to trend down, and vaccine rollouts are accelerating,\" said Lachlan Shaw, National Australia Bank's head of commodity research.</p>\n<p>\"The market's probably right to think at this price level and given what the fundamentals are doing, there'll be more supply coming into the market over time.\"</p>\n<p>U.S. crude prices also face headwinds from the loss of refinery demand after several Gulf Coast facilities were shuttered during the winter storm last week.</p>\n<p>Capacity of about 4 million barrels per day is still shut and it may take until March 5 for all of the shut capacity to resume, though there is risk of delays, analysts at J.P. Morgan said in a note this week.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Oil prices drop amid U.S. dollar strength, expectations for supply gains</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOil prices drop amid U.S. dollar strength, expectations for supply gains\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-26 13:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>SINGAPORE, Feb 26 (Reuters) - Oil prices dropped on Friday as a collapse in bond prices led to gains in the U.S. dollar and expectations grew that with oil prices back above pre-pandemic levels, more supply is likely to return to the market.</p>\n<p>U.S. West Texas Intermediate <a href=\"https://laohu8.com/S/WTI\">$(WTI)$</a> crude futures dropped 72 cents, or 1.1%, to $62.81 a barrel at 0516 GMT, giving up all of Thursday's gains.</p>\n<p>Brent crude futures for April, which expires on Friday, fell 63 cents, or 0.9%, to $66.25 a barrel, following a 16 cent loss on Thursday. The more active May contract was down 77 cents, or 1.2%, to $65.34 a barrel.</p>\n<p>\"Crude oil retreated modestly from recent highs amid a 'risk off' sentiment as Asia-Pacific equities pulled back broadly following a sour lead from Wall Street,\" said Margaret Yang, a strategist at Singapore-based DailyFX.</p>\n<p>The sell-off in bond markets, leading to a stronger U.S. dollar and rising yields, are weighing on commodities, which are non-yielding, she added.</p>\n<p>A stronger greenback makes U.S.-dollar priced oil more expensive for those buying crude in other currencies.</p>\n<p>Despite the drop in prices on Friday, both Brent and WTI are on track for gains of nearly 20% this month, as markets have grappled with supply disruptions in the United States, while optimism has built for demand to improve with vaccine rollouts.</p>\n<p>Investors are betting that next week's meeting of the Organization of the Petroleum Exporting Countries (OPEC) and allies, together called OPEC+, will result in more supply returning to the market.</p>\n<p>\"The stakes at play this time around are particularly large (for OPEC+) insofar as oil prices have more than recovered to pre-pandemic levels, global inventories are continuing to trend down, and vaccine rollouts are accelerating,\" said Lachlan Shaw, National Australia Bank's head of commodity research.</p>\n<p>\"The market's probably right to think at this price level and given what the fundamentals are doing, there'll be more supply coming into the market over time.\"</p>\n<p>U.S. crude prices also face headwinds from the loss of refinery demand after several Gulf Coast facilities were shuttered during the winter storm last week.</p>\n<p>Capacity of about 4 million barrels per day is still shut and it may take until March 5 for all of the shut capacity to resume, though there is risk of delays, analysts at J.P. Morgan said in a note this week.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DUG":"二倍做空石油与天然气ETF(ProShares)","DDG":"ProShares做空石油与天然气ETF","DWT":"三倍做空原油ETN","UCO":"二倍做多彭博原油ETF","USO":"美国原油ETF","SCO":"二倍做空彭博原油指数ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2114432037","content_text":"SINGAPORE, Feb 26 (Reuters) - Oil prices dropped on Friday as a collapse in bond prices led to gains in the U.S. dollar and expectations grew that with oil prices back above pre-pandemic levels, more supply is likely to return to the market.\nU.S. West Texas Intermediate $(WTI)$ crude futures dropped 72 cents, or 1.1%, to $62.81 a barrel at 0516 GMT, giving up all of Thursday's gains.\nBrent crude futures for April, which expires on Friday, fell 63 cents, or 0.9%, to $66.25 a barrel, following a 16 cent loss on Thursday. The more active May contract was down 77 cents, or 1.2%, to $65.34 a barrel.\n\"Crude oil retreated modestly from recent highs amid a 'risk off' sentiment as Asia-Pacific equities pulled back broadly following a sour lead from Wall Street,\" said Margaret Yang, a strategist at Singapore-based DailyFX.\nThe sell-off in bond markets, leading to a stronger U.S. dollar and rising yields, are weighing on commodities, which are non-yielding, she added.\nA stronger greenback makes U.S.-dollar priced oil more expensive for those buying crude in other currencies.\nDespite the drop in prices on Friday, both Brent and WTI are on track for gains of nearly 20% this month, as markets have grappled with supply disruptions in the United States, while optimism has built for demand to improve with vaccine rollouts.\nInvestors are betting that next week's meeting of the Organization of the Petroleum Exporting Countries (OPEC) and allies, together called OPEC+, will result in more supply returning to the market.\n\"The stakes at play this time around are particularly large (for OPEC+) insofar as oil prices have more than recovered to pre-pandemic levels, global inventories are continuing to trend down, and vaccine rollouts are accelerating,\" said Lachlan Shaw, National Australia Bank's head of commodity research.\n\"The market's probably right to think at this price level and given what the fundamentals are doing, there'll be more supply coming into the market over time.\"\nU.S. crude prices also face headwinds from the loss of refinery demand after several Gulf Coast facilities were shuttered during the winter storm last week.\nCapacity of about 4 million barrels per day is still shut and it may take until March 5 for all of the shut capacity to resume, though there is risk of delays, analysts at J.P. Morgan said in a note this week.","news_type":1},"isVote":1,"tweetType":1,"viewCount":350,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":366322276,"gmtCreate":1614397935195,"gmtModify":1704771545936,"author":{"id":"3574123214878817","authorId":"3574123214878817","name":"KP1331","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574123214878817","authorIdStr":"3574123214878817"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/366322276","repostId":"2114371822","repostType":4,"repost":{"id":"2114371822","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1614335051,"share":"https://ttm.financial/m/news/2114371822?lang=&edition=fundamental","pubTime":"2021-02-26 18:24","market":"us","language":"en","title":"Pfizer COVID-19 vaccine reduces transmission after one dose -UK study","url":"https://stock-news.laohu8.com/highlight/detail?id=2114371822","media":"Reuters","summary":"LONDON, Feb 26  - A single dose of Pfizer and BioNtech’s COVID-19 vaccine cuts the number of asymptomatic infections and could significantly reduce the risk of transmission of the virus, results of a UK study found on Friday.Researchers analysed results from thousands of COVID-19 tests carried out each week as part of hospital screenings of healthcare staff in Cambridge, eastern England.“Our findings show a dramatic reduction in the rate of positive screening tests among asymptomatic healthcare ","content":"<p>LONDON, Feb 26 (Reuters) - A single dose of Pfizer and BioNtech’s COVID-19 vaccine cuts the number of asymptomatic infections and could significantly reduce the risk of transmission of the virus, results of a UK study found on Friday.</p>\n<p>Researchers analysed results from thousands of COVID-19 tests carried out each week as part of hospital screenings of healthcare staff in Cambridge, eastern England.</p>\n<p>“Our findings show a dramatic reduction in the rate of positive screening tests among asymptomatic healthcare workers after a single dose of the Pfizer-BioNTech vaccine,” said Nick Jones, an infectious diseases specialist at Cambridge University Hospital, who co-led the study.</p>\n<p>After separating the test results from unvaccinated and vaccinated staff, Jones’ team found that 0.80% tests from unvaccinated healthcare workers were positive.</p>\n<p>This compared with 0.37% of tests from staff less than 12 days post-vaccination - when the vaccine’s protective effect is not yet fully established - and 0.20% of tests from staff at 12 days or more post-vaccination.</p>\n<p>The study and its results have yet to be independently peer-reviewed by other scientists, but were published online as a preprint on Friday.</p>\n<p>This suggests a four-fold decrease in the risk of asymptomatic COVID-19 infection amongst healthcare workers who have been vaccinated for more than 12 days, and 75% protection, said Mike Weekes, an infectious disease specialist at Cambridge University’s department of medicine, who co-led the study.</p>\n<p>The level of asymptomatic infection was also halved in those vaccinated for less than 12 days, he said.</p>\n<p>Britain has been rolling out vaccinations with both the Pfizer COVID-19 shot and one from AstraZeneca since late December 2020.</p>\n<p>“This is great news – the Pfizer vaccine not only provides protection against becoming ill from SARS-CoV-2, but also helps prevent infection, reducing the potential for the virus to be passed on to others,” Weeks said. “But we have to remember that the vaccine doesn’t give complete protection for everyone.”</p>\n<p>Key real-world data published on Wednesday from Israel, which has conducted one of the world’s fastest rollouts of Pfizer’s COVID-19 vaccine, showed that two doses of the Pfizer shot cut symptomatic COVID-19 cases by 94% across all age groups, and severe illnesses by nearly as much.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer COVID-19 vaccine reduces transmission after one dose -UK study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer COVID-19 vaccine reduces transmission after one dose -UK study\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-26 18:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LONDON, Feb 26 (Reuters) - A single dose of Pfizer and BioNtech’s COVID-19 vaccine cuts the number of asymptomatic infections and could significantly reduce the risk of transmission of the virus, results of a UK study found on Friday.</p>\n<p>Researchers analysed results from thousands of COVID-19 tests carried out each week as part of hospital screenings of healthcare staff in Cambridge, eastern England.</p>\n<p>“Our findings show a dramatic reduction in the rate of positive screening tests among asymptomatic healthcare workers after a single dose of the Pfizer-BioNTech vaccine,” said Nick Jones, an infectious diseases specialist at Cambridge University Hospital, who co-led the study.</p>\n<p>After separating the test results from unvaccinated and vaccinated staff, Jones’ team found that 0.80% tests from unvaccinated healthcare workers were positive.</p>\n<p>This compared with 0.37% of tests from staff less than 12 days post-vaccination - when the vaccine’s protective effect is not yet fully established - and 0.20% of tests from staff at 12 days or more post-vaccination.</p>\n<p>The study and its results have yet to be independently peer-reviewed by other scientists, but were published online as a preprint on Friday.</p>\n<p>This suggests a four-fold decrease in the risk of asymptomatic COVID-19 infection amongst healthcare workers who have been vaccinated for more than 12 days, and 75% protection, said Mike Weekes, an infectious disease specialist at Cambridge University’s department of medicine, who co-led the study.</p>\n<p>The level of asymptomatic infection was also halved in those vaccinated for less than 12 days, he said.</p>\n<p>Britain has been rolling out vaccinations with both the Pfizer COVID-19 shot and one from AstraZeneca since late December 2020.</p>\n<p>“This is great news – the Pfizer vaccine not only provides protection against becoming ill from SARS-CoV-2, but also helps prevent infection, reducing the potential for the virus to be passed on to others,” Weeks said. “But we have to remember that the vaccine doesn’t give complete protection for everyone.”</p>\n<p>Key real-world data published on Wednesday from Israel, which has conducted one of the world’s fastest rollouts of Pfizer’s COVID-19 vaccine, showed that two doses of the Pfizer shot cut symptomatic COVID-19 cases by 94% across all age groups, and severe illnesses by nearly as much.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2114371822","content_text":"LONDON, Feb 26 (Reuters) - A single dose of Pfizer and BioNtech’s COVID-19 vaccine cuts the number of asymptomatic infections and could significantly reduce the risk of transmission of the virus, results of a UK study found on Friday.\nResearchers analysed results from thousands of COVID-19 tests carried out each week as part of hospital screenings of healthcare staff in Cambridge, eastern England.\n“Our findings show a dramatic reduction in the rate of positive screening tests among asymptomatic healthcare workers after a single dose of the Pfizer-BioNTech vaccine,” said Nick Jones, an infectious diseases specialist at Cambridge University Hospital, who co-led the study.\nAfter separating the test results from unvaccinated and vaccinated staff, Jones’ team found that 0.80% tests from unvaccinated healthcare workers were positive.\nThis compared with 0.37% of tests from staff less than 12 days post-vaccination - when the vaccine’s protective effect is not yet fully established - and 0.20% of tests from staff at 12 days or more post-vaccination.\nThe study and its results have yet to be independently peer-reviewed by other scientists, but were published online as a preprint on Friday.\nThis suggests a four-fold decrease in the risk of asymptomatic COVID-19 infection amongst healthcare workers who have been vaccinated for more than 12 days, and 75% protection, said Mike Weekes, an infectious disease specialist at Cambridge University’s department of medicine, who co-led the study.\nThe level of asymptomatic infection was also halved in those vaccinated for less than 12 days, he said.\nBritain has been rolling out vaccinations with both the Pfizer COVID-19 shot and one from AstraZeneca since late December 2020.\n“This is great news – the Pfizer vaccine not only provides protection against becoming ill from SARS-CoV-2, but also helps prevent infection, reducing the potential for the virus to be passed on to others,” Weeks said. “But we have to remember that the vaccine doesn’t give complete protection for everyone.”\nKey real-world data published on Wednesday from Israel, which has conducted one of the world’s fastest rollouts of Pfizer’s COVID-19 vaccine, showed that two doses of the Pfizer shot cut symptomatic COVID-19 cases by 94% across all age groups, and severe illnesses by nearly as much.","news_type":1},"isVote":1,"tweetType":1,"viewCount":127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":340781774,"gmtCreate":1617493305498,"gmtModify":1704699937445,"author":{"id":"3574123214878817","authorId":"3574123214878817","name":"KP1331","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574123214878817","authorIdStr":"3574123214878817"},"themes":[],"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/340781774","repostId":"1176602902","repostType":4,"isVote":1,"tweetType":1,"viewCount":242,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320774966,"gmtCreate":1615183917755,"gmtModify":1704779225111,"author":{"id":"3574123214878817","authorId":"3574123214878817","name":"KP1331","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574123214878817","authorIdStr":"3574123214878817"},"themes":[],"htmlText":"Buy the dip!!","listText":"Buy the dip!!","text":"Buy the dip!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/320774966","repostId":"1174323549","repostType":4,"isVote":1,"tweetType":1,"viewCount":297,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":125178979,"gmtCreate":1624666188291,"gmtModify":1703843017056,"author":{"id":"3574123214878817","authorId":"3574123214878817","name":"KP1331","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574123214878817","authorIdStr":"3574123214878817"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/125178979","repostId":"1134306371","repostType":4,"repost":{"id":"1134306371","kind":"news","pubTimestamp":1624665868,"share":"https://ttm.financial/m/news/1134306371?lang=&edition=fundamental","pubTime":"2021-06-26 08:04","market":"us","language":"en","title":"US IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1134306371","media":"Renaissance Capital","summary":"16 IPOs went public in another active week for the IPO market, led by digital physicians network Dox","content":"<p>16 IPOs went public in another active week for the IPO market, led by digital physicians network&nbsp;<b>Doximity</b>(DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as one postponement, Chinese social networking platform&nbsp;<b>Soulgate</b>(SSR).</p>\n<p><b>Doximity</b>&nbsp;(DOCS) priced above the range to raise $606 million at a $5.5 billion market cap. Doximity claims that it is the leading digital platform for US medical professionals, allowing collaboration with colleagues and secure coordination of patient care, among other features. While growth may slow as conditions normalize post-pandemic, the company has a sticky customer base and strong track record of profitability. Doximity finished up 115%.</p>\n<p>The largest deal of the week, Chinese freight platform&nbsp;<b>Full Truck Alliance</b>(YMM) priced at the high end to raise $1.6 billion at a $20.8 billion market cap. Full Truck states that it is the world's largest digital freight platform by gross transaction value (GTV), facilitating 22+ million fulfilled orders with GTV of nearly $8 billion in the 1Q21. The company is unprofitable though free cash flow turned positive in 2020. Full Truck finished up 4%.</p>\n<p>Integrated insurer&nbsp;<b>Bright Health Group</b>(BHG) downsized and priced below the range to raise $924 million at a $12.7 billion market cap. Through a multi-pronged organic and inorganic growth strategy, the company’s core business has grown to serve roughly 623,000 patients in 14 states since its founding. However, the company is unprofitable, and its medical cost ratio has increased over the last several years. Bright Health finished down 4%.</p>\n<p><b>Confluent</b>(CFLT) priced above the range to raise $828 million at an $11.7 billion market cap. Founded by the original creators of Apache Kafka, Confluent’s data infrastructure offering is designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. The company has demonstrated growth but S&amp;M spending has widened losses. Confluent finished up 28%.</p>\n<p>Car wash brand&nbsp;<b>Mister Car Wash</b>(MCW) priced at the low end to raise $563 million at a $4.9 billion market cap. Profitable with strong margins and solid cash flow, Mister Car Wash is the largest national car wash brand in the US, with 344 locations in 21 states. The company is slightly concentrated in certain states, and it is leveraged post-IPO. Mister Car Wash finished up 35%.</p>\n<p>HR services provider&nbsp;<b>First Advantage</b>(FA) upsized and priced at the high end to raise $383 million at a $2.3 billion market cap. Profitable with positive cash flow, First Advantage provides solutions for screening, verifications, safety, and compliance related to human capital. The company operates in a highly competitive market, and revenue depends on hiring rates. First Advantage finished up 37%.</p>\n<p>Chinese grocery delivery platform&nbsp;<b>Missfresh</b>(MF) priced at the low end to raise $273 million at a $3.2 billion market cap. Missfresh’s mobile app and Mini Program allow consumers to purchase groceries from their phone, which are then delivered to their door by a delivery driver. The company is a leader in its market, though it is unprofitable, and revenue declined in the 1Q21. Missfresh finished down 26%.</p>\n<p>Customer experience software provider&nbsp;<b>Sprinklr</b>(CXM) downsized and priced below the range to raise $266 million at a $4.6 billion market cap. Sprinklr provides a software platform that helps enterprises create a persistent, unified view of each customer at scale. The company has improved its gross margins, though it is historically unprofitable due to high S&amp;M costs. Sprinklr finished up 28%.</p>\n<p>Gene editing biotech&nbsp;<b>Graphite Bio</b>(GRPH) upsized and priced at the high end to raise $238 million at a $999 million market cap. Graphite's lead candidate aims to correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expression. The company has received IND clearance and intends to enroll a Phase 1/2 trial in the 2H21, with initial data expected by the end of 2022. Graphite finished up 9%.</p>\n<p>Oncology biotech&nbsp;<b>Monte Rosa Therapeutics</b>(GLUE) upsized and priced at the high end to raise $222 million at a $911 million market cap. The company plans to select one of its selective, orally bioavailable GSPT1-directed MGD molecules for use in a genetically-defined subset of non-small cell lung cancer patients by the 2H21, and submit an IND in the 1H22. Monte Rosa finished down 1%.</p>\n<p>Irish DMT biotech&nbsp;<b>GH Research</b>(GHRS) upsized and priced at the high end to raise $160 million at an $809 million market cap. The company is developing its proprietary 5-MeO-DMT compound in a Phase 2 trial in the Netherlands for patients with Treatment-Resistant Depression. GH Research finished up 20%.</p>\n<p>Oncology biotech&nbsp;<b>Elevation Oncology</b>(ELEV) priced at the midpoint to raise $100 million at a $403 million market cap. Elevation's lead program is focused on neuregulin-1, or NRG1, fusions. It has initiated a Phase 2 trial of seribantumab, an anti-HER3 monoclonal antibody, in advanced solid tumors harboring an NRG1 fusion. Elevation finished down 29%.</p>\n<p>Biopharmaceutical reagents provider&nbsp;<b>Alpha Teknova</b>(TKNO) upsized and priced at the high end to raise $96 million at a $470 million market cap. Alpha Teknova provides critical reagents that enable the discovery, research, development and production of biopharmaceutical products. As of March 31, 2021, Alpha Teknova had over 3,000 active customers. Alpha Teknova finished up 56%.</p>\n<p><b>Miromatrix Medical</b>&nbsp;(MIRO) upsized and priced at the high end to raise $43 million at a $191 million market cap. Miromatrix is developing a novel technology for bioengineering fully transplantable organs, initially focused on livers and kidneys. The company has demonstrated functional vasculature and important organ function in preclinical studies, and hopes to initiate a Phase 1 trial in late 2022 with its External Liver Assist Product. Miromatrix finished up 42%.</p>\n<p>Antibiotic biotech&nbsp;<b>Acurx Pharmaceuticals</b>(ACXP) priced at the midpoint to raise $15 million at a $62 million market cap. The company is developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the WHO, CDC, and USDA. Its lead candidate recently completed a Phase 2a trial in patients with C. difficile infections, and is expected to begin a Phase 2b trial this year. Acurx finished up 32%.</p>\n<p>CBD products maker&nbsp;<b>Grove</b>(GRVI) priced at the midpoint to raise $11 million at a $79 million market cap. Fast growing and profitable in the 9mo FY21, Grove develops, produces, markets, and sells raw materials, white label products, and end consumer products containing the industrial hemp plant extract, Cannabidiol (CBD). Grove finished up 57%.</p>\n<p>Four SPACs raised $520 million led by&nbsp;<b>FinTech Acquisition VI</b>(FTVIU), which raised $220 million.</p>\n<p><img src=\"https://static.tigerbbs.com/ddaee6ee8ea0594af65c20afe2b09fb2\" tg-width=\"1057\" tg-height=\"708\"><img src=\"https://static.tigerbbs.com/adbfd8143d6b3c07799a5b5568126eae\" tg-width=\"1059\" tg-height=\"498\"></p>\n<p>23 IPOs submitted initial filings. Chinese vaping brand&nbsp;<b>Aspire Global</b>(ASPG) plans to raise $161 million. Fitness franchise&nbsp;<b>F45 Training</b>(FXLV), luxury social club operator&nbsp;<b>Membership Collective</b>(MCG), soft drink maker&nbsp;<b>Zevia</b>(ZVIA), specialty insurer&nbsp;<b>Ryan Specialty Group</b>(RYAN), ocular medical device maker&nbsp;<b>Sight Sciences</b>(SGHT), Italy-based<b>Stevanato Group</b>(STVN), real estate manager&nbsp;<b>Bridge Investment Group</b>(BRDG), consumer banking platform&nbsp;<b>Blend Labs</b>(BLND), database developer<b>Couchbase</b>(BASE), interior design software provider&nbsp;<b>Manycore Tech</b>(KOOL), Chinese tutoring platform&nbsp;<b>Spark Education</b>(SPRK), oncology biotech&nbsp;<b>Vividion Therapeutics</b>(VVID), e-commerce platform&nbsp;<b>VTEX</b>(VTEX), digital marketing services provider&nbsp;<b>Gambling.com Group</b>(GAMB), bone marrow disease biotech&nbsp;<b>Imago BioSciences</b>(IMGO), French biotech&nbsp;<b>Dynacure</b>(DYCU), microbial testing device provider&nbsp;<b>Rapid Micro Biosystems</b>(RPID), legal software provider&nbsp;<b>CS Disco</b>(LAW), oncology biotechs&nbsp;<b>Erasca</b>(ERAS) and&nbsp;<b>Candel Therapeutics</b>(CADL), and fitness franchisor&nbsp;<b>Xponential Fitness</b>(XPOF) all filed to raise $100 million. Medical imaging software provider&nbsp;<b>Perspectum Group</b>(SCAN) filed to raise $75 million.</p>\n<p>10 SPACs submitted initial filings led by Sagansky and Sloan’s&nbsp;<b>Spinning Eagle Acquisition</b>(SPNGU), which plans to raise $2 billion.</p>\n<img src=\"https://static.tigerbbs.com/5405c3b71416d44598b8debbc72ba0c6\" tg-width=\"1059\" tg-height=\"707\">\n<img src=\"https://static.tigerbbs.com/7d74d7af7f2c5dced4672868bf036d03\" tg-width=\"1058\" tg-height=\"663\">\n<img src=\"https://static.tigerbbs.com/1e4854a0e989f2eb5923924d3cdf1083\" tg-width=\"1060\" tg-height=\"554\">\n<p>This past week, Renaissance Capital released its2Q 2021 US IPO Market Review, exploring the second quarter’s record-breaking activity, best and worst performers, and outlook for the 3Q.</p>\n<p><b>IPO Market Snapshot</b></p>\n<p>The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 6/24/21, the Renaissance IPO Index was up 2.7% year-to-date, while the S&amp;P 500 was up 13.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 1.5% year-to-date, while the ACWX was up 10.3%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.</p>\n<table>\n <thead>\n  <tr></tr>\n </thead>\n</table>","source":"lsy1603787993745","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Weekly Recap: Doximity pops more than 100% in a 16 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-26 08:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/83314/US-IPO-Weekly-Recap-Doximity-pops-more-than-100-in-a-16-IPO-week><strong>Renaissance Capital</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>16 IPOs went public in another active week for the IPO market, led by digital physicians network Doximity(DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/83314/US-IPO-Weekly-Recap-Doximity-pops-more-than-100-in-a-16-IPO-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","CFLT":"Confluent, Inc.","FA":"First Advantage Corp.","MF":"每日优鲜","GHRS":"GH Research PLC","DOCS":"Doximity, Inc.","ELEV":"Elevation Oncology, Inc.","CXM":"Sprinklr, Inc.","GLUE":"Monte Rosa Therapeutics",".DJI":"道琼斯","TKNO":"Alpha Teknova, Inc.","ACXP":"Acurx Pharmaceuticals, LLC*","MCW":"Mister Car Wash, Inc.","YMM":"满帮",".IXIC":"NASDAQ Composite"},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/83314/US-IPO-Weekly-Recap-Doximity-pops-more-than-100-in-a-16-IPO-week","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134306371","content_text":"16 IPOs went public in another active week for the IPO market, led by digital physicians network Doximity(DOCS), which soared 104% in its debut. The week’s IPOs were joined by four SPACs, as well as one postponement, Chinese social networking platform Soulgate(SSR).\nDoximity (DOCS) priced above the range to raise $606 million at a $5.5 billion market cap. Doximity claims that it is the leading digital platform for US medical professionals, allowing collaboration with colleagues and secure coordination of patient care, among other features. While growth may slow as conditions normalize post-pandemic, the company has a sticky customer base and strong track record of profitability. Doximity finished up 115%.\nThe largest deal of the week, Chinese freight platform Full Truck Alliance(YMM) priced at the high end to raise $1.6 billion at a $20.8 billion market cap. Full Truck states that it is the world's largest digital freight platform by gross transaction value (GTV), facilitating 22+ million fulfilled orders with GTV of nearly $8 billion in the 1Q21. The company is unprofitable though free cash flow turned positive in 2020. Full Truck finished up 4%.\nIntegrated insurer Bright Health Group(BHG) downsized and priced below the range to raise $924 million at a $12.7 billion market cap. Through a multi-pronged organic and inorganic growth strategy, the company’s core business has grown to serve roughly 623,000 patients in 14 states since its founding. However, the company is unprofitable, and its medical cost ratio has increased over the last several years. Bright Health finished down 4%.\nConfluent(CFLT) priced above the range to raise $828 million at an $11.7 billion market cap. Founded by the original creators of Apache Kafka, Confluent’s data infrastructure offering is designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. The company has demonstrated growth but S&M spending has widened losses. Confluent finished up 28%.\nCar wash brand Mister Car Wash(MCW) priced at the low end to raise $563 million at a $4.9 billion market cap. Profitable with strong margins and solid cash flow, Mister Car Wash is the largest national car wash brand in the US, with 344 locations in 21 states. The company is slightly concentrated in certain states, and it is leveraged post-IPO. Mister Car Wash finished up 35%.\nHR services provider First Advantage(FA) upsized and priced at the high end to raise $383 million at a $2.3 billion market cap. Profitable with positive cash flow, First Advantage provides solutions for screening, verifications, safety, and compliance related to human capital. The company operates in a highly competitive market, and revenue depends on hiring rates. First Advantage finished up 37%.\nChinese grocery delivery platform Missfresh(MF) priced at the low end to raise $273 million at a $3.2 billion market cap. Missfresh’s mobile app and Mini Program allow consumers to purchase groceries from their phone, which are then delivered to their door by a delivery driver. The company is a leader in its market, though it is unprofitable, and revenue declined in the 1Q21. Missfresh finished down 26%.\nCustomer experience software provider Sprinklr(CXM) downsized and priced below the range to raise $266 million at a $4.6 billion market cap. Sprinklr provides a software platform that helps enterprises create a persistent, unified view of each customer at scale. The company has improved its gross margins, though it is historically unprofitable due to high S&M costs. Sprinklr finished up 28%.\nGene editing biotech Graphite Bio(GRPH) upsized and priced at the high end to raise $238 million at a $999 million market cap. Graphite's lead candidate aims to correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expression. The company has received IND clearance and intends to enroll a Phase 1/2 trial in the 2H21, with initial data expected by the end of 2022. Graphite finished up 9%.\nOncology biotech Monte Rosa Therapeutics(GLUE) upsized and priced at the high end to raise $222 million at a $911 million market cap. The company plans to select one of its selective, orally bioavailable GSPT1-directed MGD molecules for use in a genetically-defined subset of non-small cell lung cancer patients by the 2H21, and submit an IND in the 1H22. Monte Rosa finished down 1%.\nIrish DMT biotech GH Research(GHRS) upsized and priced at the high end to raise $160 million at an $809 million market cap. The company is developing its proprietary 5-MeO-DMT compound in a Phase 2 trial in the Netherlands for patients with Treatment-Resistant Depression. GH Research finished up 20%.\nOncology biotech Elevation Oncology(ELEV) priced at the midpoint to raise $100 million at a $403 million market cap. Elevation's lead program is focused on neuregulin-1, or NRG1, fusions. It has initiated a Phase 2 trial of seribantumab, an anti-HER3 monoclonal antibody, in advanced solid tumors harboring an NRG1 fusion. Elevation finished down 29%.\nBiopharmaceutical reagents provider Alpha Teknova(TKNO) upsized and priced at the high end to raise $96 million at a $470 million market cap. Alpha Teknova provides critical reagents that enable the discovery, research, development and production of biopharmaceutical products. As of March 31, 2021, Alpha Teknova had over 3,000 active customers. Alpha Teknova finished up 56%.\nMiromatrix Medical (MIRO) upsized and priced at the high end to raise $43 million at a $191 million market cap. Miromatrix is developing a novel technology for bioengineering fully transplantable organs, initially focused on livers and kidneys. The company has demonstrated functional vasculature and important organ function in preclinical studies, and hopes to initiate a Phase 1 trial in late 2022 with its External Liver Assist Product. Miromatrix finished up 42%.\nAntibiotic biotech Acurx Pharmaceuticals(ACXP) priced at the midpoint to raise $15 million at a $62 million market cap. The company is developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the WHO, CDC, and USDA. Its lead candidate recently completed a Phase 2a trial in patients with C. difficile infections, and is expected to begin a Phase 2b trial this year. Acurx finished up 32%.\nCBD products maker Grove(GRVI) priced at the midpoint to raise $11 million at a $79 million market cap. Fast growing and profitable in the 9mo FY21, Grove develops, produces, markets, and sells raw materials, white label products, and end consumer products containing the industrial hemp plant extract, Cannabidiol (CBD). Grove finished up 57%.\nFour SPACs raised $520 million led by FinTech Acquisition VI(FTVIU), which raised $220 million.\n\n23 IPOs submitted initial filings. Chinese vaping brand Aspire Global(ASPG) plans to raise $161 million. Fitness franchise F45 Training(FXLV), luxury social club operator Membership Collective(MCG), soft drink maker Zevia(ZVIA), specialty insurer Ryan Specialty Group(RYAN), ocular medical device maker Sight Sciences(SGHT), Italy-basedStevanato Group(STVN), real estate manager Bridge Investment Group(BRDG), consumer banking platform Blend Labs(BLND), database developerCouchbase(BASE), interior design software provider Manycore Tech(KOOL), Chinese tutoring platform Spark Education(SPRK), oncology biotech Vividion Therapeutics(VVID), e-commerce platform VTEX(VTEX), digital marketing services provider Gambling.com Group(GAMB), bone marrow disease biotech Imago BioSciences(IMGO), French biotech Dynacure(DYCU), microbial testing device provider Rapid Micro Biosystems(RPID), legal software provider CS Disco(LAW), oncology biotechs Erasca(ERAS) and Candel Therapeutics(CADL), and fitness franchisor Xponential Fitness(XPOF) all filed to raise $100 million. Medical imaging software provider Perspectum Group(SCAN) filed to raise $75 million.\n10 SPACs submitted initial filings led by Sagansky and Sloan’s Spinning Eagle Acquisition(SPNGU), which plans to raise $2 billion.\n\n\n\nThis past week, Renaissance Capital released its2Q 2021 US IPO Market Review, exploring the second quarter’s record-breaking activity, best and worst performers, and outlook for the 3Q.\nIPO Market Snapshot\nThe Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 6/24/21, the Renaissance IPO Index was up 2.7% year-to-date, while the S&P 500 was up 13.6%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Snowflake (SNOW) and Palantir Technologies (PLTR). The Renaissance International IPO Index was down 1.5% year-to-date, while the ACWX was up 10.3%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks the index, and top ETF holdings include Smoore International and EQT Partners.","news_type":1},"isVote":1,"tweetType":1,"viewCount":254,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":366322276,"gmtCreate":1614397935195,"gmtModify":1704771545936,"author":{"id":"3574123214878817","authorId":"3574123214878817","name":"KP1331","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574123214878817","authorIdStr":"3574123214878817"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/366322276","repostId":"2114371822","repostType":4,"repost":{"id":"2114371822","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1614335051,"share":"https://ttm.financial/m/news/2114371822?lang=&edition=fundamental","pubTime":"2021-02-26 18:24","market":"us","language":"en","title":"Pfizer COVID-19 vaccine reduces transmission after one dose -UK study","url":"https://stock-news.laohu8.com/highlight/detail?id=2114371822","media":"Reuters","summary":"LONDON, Feb 26  - A single dose of Pfizer and BioNtech’s COVID-19 vaccine cuts the number of asymptomatic infections and could significantly reduce the risk of transmission of the virus, results of a UK study found on Friday.Researchers analysed results from thousands of COVID-19 tests carried out each week as part of hospital screenings of healthcare staff in Cambridge, eastern England.“Our findings show a dramatic reduction in the rate of positive screening tests among asymptomatic healthcare ","content":"<p>LONDON, Feb 26 (Reuters) - A single dose of Pfizer and BioNtech’s COVID-19 vaccine cuts the number of asymptomatic infections and could significantly reduce the risk of transmission of the virus, results of a UK study found on Friday.</p>\n<p>Researchers analysed results from thousands of COVID-19 tests carried out each week as part of hospital screenings of healthcare staff in Cambridge, eastern England.</p>\n<p>“Our findings show a dramatic reduction in the rate of positive screening tests among asymptomatic healthcare workers after a single dose of the Pfizer-BioNTech vaccine,” said Nick Jones, an infectious diseases specialist at Cambridge University Hospital, who co-led the study.</p>\n<p>After separating the test results from unvaccinated and vaccinated staff, Jones’ team found that 0.80% tests from unvaccinated healthcare workers were positive.</p>\n<p>This compared with 0.37% of tests from staff less than 12 days post-vaccination - when the vaccine’s protective effect is not yet fully established - and 0.20% of tests from staff at 12 days or more post-vaccination.</p>\n<p>The study and its results have yet to be independently peer-reviewed by other scientists, but were published online as a preprint on Friday.</p>\n<p>This suggests a four-fold decrease in the risk of asymptomatic COVID-19 infection amongst healthcare workers who have been vaccinated for more than 12 days, and 75% protection, said Mike Weekes, an infectious disease specialist at Cambridge University’s department of medicine, who co-led the study.</p>\n<p>The level of asymptomatic infection was also halved in those vaccinated for less than 12 days, he said.</p>\n<p>Britain has been rolling out vaccinations with both the Pfizer COVID-19 shot and one from AstraZeneca since late December 2020.</p>\n<p>“This is great news – the Pfizer vaccine not only provides protection against becoming ill from SARS-CoV-2, but also helps prevent infection, reducing the potential for the virus to be passed on to others,” Weeks said. “But we have to remember that the vaccine doesn’t give complete protection for everyone.”</p>\n<p>Key real-world data published on Wednesday from Israel, which has conducted one of the world’s fastest rollouts of Pfizer’s COVID-19 vaccine, showed that two doses of the Pfizer shot cut symptomatic COVID-19 cases by 94% across all age groups, and severe illnesses by nearly as much.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer COVID-19 vaccine reduces transmission after one dose -UK study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer COVID-19 vaccine reduces transmission after one dose -UK study\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-26 18:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LONDON, Feb 26 (Reuters) - A single dose of Pfizer and BioNtech’s COVID-19 vaccine cuts the number of asymptomatic infections and could significantly reduce the risk of transmission of the virus, results of a UK study found on Friday.</p>\n<p>Researchers analysed results from thousands of COVID-19 tests carried out each week as part of hospital screenings of healthcare staff in Cambridge, eastern England.</p>\n<p>“Our findings show a dramatic reduction in the rate of positive screening tests among asymptomatic healthcare workers after a single dose of the Pfizer-BioNTech vaccine,” said Nick Jones, an infectious diseases specialist at Cambridge University Hospital, who co-led the study.</p>\n<p>After separating the test results from unvaccinated and vaccinated staff, Jones’ team found that 0.80% tests from unvaccinated healthcare workers were positive.</p>\n<p>This compared with 0.37% of tests from staff less than 12 days post-vaccination - when the vaccine’s protective effect is not yet fully established - and 0.20% of tests from staff at 12 days or more post-vaccination.</p>\n<p>The study and its results have yet to be independently peer-reviewed by other scientists, but were published online as a preprint on Friday.</p>\n<p>This suggests a four-fold decrease in the risk of asymptomatic COVID-19 infection amongst healthcare workers who have been vaccinated for more than 12 days, and 75% protection, said Mike Weekes, an infectious disease specialist at Cambridge University’s department of medicine, who co-led the study.</p>\n<p>The level of asymptomatic infection was also halved in those vaccinated for less than 12 days, he said.</p>\n<p>Britain has been rolling out vaccinations with both the Pfizer COVID-19 shot and one from AstraZeneca since late December 2020.</p>\n<p>“This is great news – the Pfizer vaccine not only provides protection against becoming ill from SARS-CoV-2, but also helps prevent infection, reducing the potential for the virus to be passed on to others,” Weeks said. “But we have to remember that the vaccine doesn’t give complete protection for everyone.”</p>\n<p>Key real-world data published on Wednesday from Israel, which has conducted one of the world’s fastest rollouts of Pfizer’s COVID-19 vaccine, showed that two doses of the Pfizer shot cut symptomatic COVID-19 cases by 94% across all age groups, and severe illnesses by nearly as much.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2114371822","content_text":"LONDON, Feb 26 (Reuters) - A single dose of Pfizer and BioNtech’s COVID-19 vaccine cuts the number of asymptomatic infections and could significantly reduce the risk of transmission of the virus, results of a UK study found on Friday.\nResearchers analysed results from thousands of COVID-19 tests carried out each week as part of hospital screenings of healthcare staff in Cambridge, eastern England.\n“Our findings show a dramatic reduction in the rate of positive screening tests among asymptomatic healthcare workers after a single dose of the Pfizer-BioNTech vaccine,” said Nick Jones, an infectious diseases specialist at Cambridge University Hospital, who co-led the study.\nAfter separating the test results from unvaccinated and vaccinated staff, Jones’ team found that 0.80% tests from unvaccinated healthcare workers were positive.\nThis compared with 0.37% of tests from staff less than 12 days post-vaccination - when the vaccine’s protective effect is not yet fully established - and 0.20% of tests from staff at 12 days or more post-vaccination.\nThe study and its results have yet to be independently peer-reviewed by other scientists, but were published online as a preprint on Friday.\nThis suggests a four-fold decrease in the risk of asymptomatic COVID-19 infection amongst healthcare workers who have been vaccinated for more than 12 days, and 75% protection, said Mike Weekes, an infectious disease specialist at Cambridge University’s department of medicine, who co-led the study.\nThe level of asymptomatic infection was also halved in those vaccinated for less than 12 days, he said.\nBritain has been rolling out vaccinations with both the Pfizer COVID-19 shot and one from AstraZeneca since late December 2020.\n“This is great news – the Pfizer vaccine not only provides protection against becoming ill from SARS-CoV-2, but also helps prevent infection, reducing the potential for the virus to be passed on to others,” Weeks said. “But we have to remember that the vaccine doesn’t give complete protection for everyone.”\nKey real-world data published on Wednesday from Israel, which has conducted one of the world’s fastest rollouts of Pfizer’s COVID-19 vaccine, showed that two doses of the Pfizer shot cut symptomatic COVID-19 cases by 94% across all age groups, and severe illnesses by nearly as much.","news_type":1},"isVote":1,"tweetType":1,"viewCount":127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":325896513,"gmtCreate":1615883992132,"gmtModify":1704787885492,"author":{"id":"3574123214878817","authorId":"3574123214878817","name":"KP1331","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574123214878817","authorIdStr":"3574123214878817"},"themes":[],"htmlText":"Cool&nbsp;","listText":"Cool&nbsp;","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/325896513","repostId":"1158082879","repostType":4,"isVote":1,"tweetType":1,"viewCount":580,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":367072423,"gmtCreate":1614900106462,"gmtModify":1704776680523,"author":{"id":"3574123214878817","authorId":"3574123214878817","name":"KP1331","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574123214878817","authorIdStr":"3574123214878817"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/367072423","repostId":"1178192831","repostType":4,"isVote":1,"tweetType":1,"viewCount":169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":364600766,"gmtCreate":1614841855455,"gmtModify":1704775882873,"author":{"id":"3574123214878817","authorId":"3574123214878817","name":"KP1331","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574123214878817","authorIdStr":"3574123214878817"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/364600766","repostId":"1195543456","repostType":4,"repost":{"id":"1195543456","kind":"news","pubTimestamp":1614840785,"share":"https://ttm.financial/m/news/1195543456?lang=&edition=fundamental","pubTime":"2021-03-04 14:53","market":"us","language":"en","title":"ARK Invest snaps up Zoom shares in wake of earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=1195543456","media":"seekingalpha","summary":"ARK Investment Management bought 255,621 shares of Zoom  Media yesterday for its flagship ARK Innova","content":"<p>ARK Investment Management bought 255,621 shares of <a href=\"https://laohu8.com/S/ZM\">Zoom</a>  Media&nbsp;yesterday for its flagship <a href=\"https://laohu8.com/S/ARKK\">ARK Innovation ETF</a>.</p><p>The move brought Zoom up to 0.4048% of the fund.</p><p>ZM is&nbsp;down 2.4%&nbsp;today, while ARKK is&nbsp;down 2.6%&nbsp;amid pressure from resurgent yields on high-value and tech stocks.</p><p>Zoom shares saw a post-earnings pop of nearly 10% Monday, with its outlook suggestingfurther tailwinds for work-from-home companies.</p><p>But it fell right back down Tuesday, losing 9%, despite an upgrade from Piper Sandler thatsuggested further upside.</p><p>Zoom is up more than 10% year to date.</p><p>Among other buys, ARK added 227,600 shares of JD.com(NASDAQ:JD)and 92,982 shares of <a href=\"https://laohu8.com/S/FB\">Facebook</a> to the <a href=\"https://laohu8.com/S/ARKW\">ARK Next Generation Internet ETF</a> .</p><p>Facebook is&nbsp;up 0.4%, JD.com is&nbsp;off 0.4%&nbsp;and ARKW is&nbsp;down 1.4%.</p><p>On Friday, ARKK saw itssecond-highest level of inflows ever at $464M.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ARK Invest snaps up Zoom shares in wake of earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nARK Invest snaps up Zoom shares in wake of earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-04 14:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3668823-ark-invest-snaps-up-zoom-shares><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ARK Investment Management bought 255,621 shares of Zoom  Media yesterday for its flagship ARK Innovation ETF.The move brought Zoom up to 0.4048% of the fund.ZM is down 2.4% today, while ARKK is down ...</p>\n\n<a href=\"https://seekingalpha.com/news/3668823-ark-invest-snaps-up-zoom-shares\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKK":"ARK Innovation ETF","ARKW":"ARK Next Generation Internation ETF","ZM":"Zoom"},"source_url":"https://seekingalpha.com/news/3668823-ark-invest-snaps-up-zoom-shares","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1195543456","content_text":"ARK Investment Management bought 255,621 shares of Zoom  Media yesterday for its flagship ARK Innovation ETF.The move brought Zoom up to 0.4048% of the fund.ZM is down 2.4% today, while ARKK is down 2.6% amid pressure from resurgent yields on high-value and tech stocks.Zoom shares saw a post-earnings pop of nearly 10% Monday, with its outlook suggestingfurther tailwinds for work-from-home companies.But it fell right back down Tuesday, losing 9%, despite an upgrade from Piper Sandler thatsuggested further upside.Zoom is up more than 10% year to date.Among other buys, ARK added 227,600 shares of JD.com(NASDAQ:JD)and 92,982 shares of Facebook to the ARK Next Generation Internet ETF .Facebook is up 0.4%, JD.com is off 0.4% and ARKW is down 1.4%.On Friday, ARKK saw itssecond-highest level of inflows ever at $464M.","news_type":1},"isVote":1,"tweetType":1,"viewCount":251,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":365260620,"gmtCreate":1614746716260,"gmtModify":1704774723999,"author":{"id":"3574123214878817","authorId":"3574123214878817","name":"KP1331","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574123214878817","authorIdStr":"3574123214878817"},"themes":[],"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/365260620","repostId":"1178860453","repostType":4,"isVote":1,"tweetType":1,"viewCount":394,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":362598167,"gmtCreate":1614647244259,"gmtModify":1704773461966,"author":{"id":"3574123214878817","authorId":"3574123214878817","name":"KP1331","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574123214878817","authorIdStr":"3574123214878817"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/362598167","repostId":"1143415407","repostType":4,"isVote":1,"tweetType":1,"viewCount":210,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":366740950,"gmtCreate":1614566981770,"gmtModify":1704772494210,"author":{"id":"3574123214878817","authorId":"3574123214878817","name":"KP1331","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574123214878817","authorIdStr":"3574123214878817"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/366740950","repostId":"2114432037","repostType":4,"isVote":1,"tweetType":1,"viewCount":350,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}